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resumo 
 
 
Entre os diversos tipos de interações entre células que ocorrem no 
organismo, a interação entre o oócito e o espermatozoide é de grande 
importância para a perpetuação da espécie. A adesão celular é então 
um processo fundamental para a fertilização, a qual envolve a zona 
pelúcida (ZP) dos oócitos, a primeira barreira encontrada pelos 
espermatozoides que medeia a primeira interação entre os gâmetas. A 
ZP3 é uma das principais proteínas da ZP, e ainda não se conhece qual 
o seu ligando no espermatozoide. A glicoproteína APP foi descrita por 
nós como estando presente na cabeça do espermatozoide, em 
particular na zona equatorial, envolvida na interação espermatozoide-
oócito. Esta proteína é central à patogénese da Doença de Alzheimer e 
os seus papéis fisiológicos ainda não estão bem caracterizados. Este 
trabalho focou-se na caracterização de um possível interação entre a 
APP e a ZP3 na adesão célula-célula. Foi realizado um levantamento 
de motivos funcionais relevantes no ZP3, e avaliado o papel deste e da 
APP na adesão célula-célula. Para tal foram realizados ensaios de 
interferência com anticorpos contra epitopos da APP, da ZP3, e 
também da β1-integrina, um proteína importante na adesão celular e 
que se sabe ligar à APP. A co-localização subcelular entre a ZP3 e a 
APP foi analisada por imunocitoquímica, e uma possível interação física 
entre a ZP3 e APP monitorizada através de ensaios de 
imunoprecipitação. Os resultados indicam que, de entre as proteínas 
estudadas, a APP e a β1-integrina são as mais importantes na adesão 
celular, provavelmente através de uma via comum. A ZP3 parece ter 
apenas um pequeno efeito na adesão célula-célula, possivelmente 
através da mesma via da APP e da β1-integrina. Surpreendentemente, 
ZP3 e APP apresentam pouca co-localização, e especialmente em 
vesiculas perto do complexo de Golgi. Contudo, existe um maior grau 
de co-localização entre a ZP3 e a β1-integrina, particularmente perto da 
membrana plasmática. Inesperada foi também a presença de 
agregados extracelulares de ZP3 secretada contendo também APP. Os 
resultados preliminares dos ensaios de imunoprecipitação sugerem 
uma interacção física entre as formas altamente glicosiladas da APP e 
da ZP3, o que pode refletir uma importante interação destas duas 
proteínas na ZP do oócito aquando da fertilização. 
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Among different types of cell-cell interactions present in the body, the 
interaction between the oocyte and a sperm cell is of great 
importance for species perpetuation. Cellular adhesion is thus a 
crucial process in fertilization, which involves the oocyte’s zona 
pellucida (ZP), the first barrier found by sperm cells that mediates the 
first contact between gametes. ZP3 is a major ZP glycoprotein of the 
oocyte, and its ligand in sperm cells is still unknown. The APP 
glycoprotein was found by us to be in the sperm’s head, including its 
equatorial zone involved in sperm-oocyte interaction. This protein 
plays a role in the pathogenesis of the Alzheimer’s disease and its 
physiologic roles are still being unravelled. The present work aimed 
to characterize a putative APP-ZP3 interaction in cell-cell adhesion. 
Relevant functional motifs on the ZP3 amino acid sequence were 
analysed, and the role of ZP3 and APP in cell-cell adhesion was 
evaluated. Interference assays were performed with antibodies 
against epitopes of APP, ZP3 and β1-integrin, the latter an important 
protein in cellular adhesion known to bind APP. The subcellular co-
localization of ZP3 and APP was analysed by immunocytochemistry 
assays, and a potential physical interaction between ZP3 and APP 
was evaluated by immunoprecipitation. Results indicate that, from the 
studied proteins, APP and β1-integrin are the most important in cell-
cell adhesion, probably through a common pathway. ZP3 has only a 
minor effect in cell-cell adhesion, but is able to interfere with 
adhesion mediated by APP and β1-integrin, potentially sharing their 
common pathway. Surprisingly, ZP3 and APP only co-localize at low 
quantities in vesicles, mainly near the Golgi apparatus, while there is 
a slightly higher degree of co-localization between ZP3 and β1-
integrin near the plasma membrane. Unexpectedly though, ZP3 and 
APP were found to co-localize in extracellular aggregates of secreted 
ZP3. Immunoprecipitation results so far further suggest that highly 
glycosylated ZP3 and APP forms physically interact, what may reflect 
an important interaction between these proteins in   the oocyte’s ZP 
upon fertilization. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SACS/UA 2014 
 
Analysis of The Role of ZP3 and APP Cell-Cell Adhesion 1 
 
Index 
 
1. Abbreviations.................................................................................... 3 
2. Introduction.......................................................................................  5 
2.1. Zona Pellucida (ZP) Glycoproteins .................................................... 6 
2.1.1. Evolution of ZP Genes................................................................ .......... 7 
2.1.2. Structure and Function of ZP Glycoproteins..............................  10 
2.1.2.1. Zona Pellucida Glycoprotein 1 (ZP1)............................................ 10 
2.1.2.2. Zona Pellucida Glycoprotein 2 (ZP2) ..........................................  11 
2.1.2.3. Zona Pellucida Glycoprotein 3 (ZP3)...........................................  11 
2.1.2.4. Zona Pellucida Glycoprotein 4 (ZP4)...........................................  12 
2.1.3. Secretion and Assembly of ZP Glycoproteins............................ 13 
2.1.4. Proteins in Sperm-Egg Interactions...........................................  16 
2.1.5. Sperm Proteins Involved in Sperm-Egg Interactions…….......... 17 
2.1.5.1. GalT............................................................................................ 17 
2.1.5.2. A Desintegrin and A Metalloproteinase (ADAM)......................... 17 
2.1.5.3. Zonadhesin................................................................................. 18 
2.1.5.4. IZUMO........................................................................................ 19 
2.1.6. Oocyte Proteins Involved in Sperm-Egg Interactions................. 19 
2.1.6.1. Integrins........................................................................................ 19 
2.1.6.2. CD9............................................................................................... 20 
2.2. Alzheimer’s Amyloid Precursor Protein (APP)………........................21 
2.2.1. APP Proteolytic Processing........................................................ 22 
2.2.2. APP Isoforms.............................................................................. 23 
2.2.3. APP Dimerization....................................................................... 26 
2.2.4 APP in Sperm Cells.................................................................... 27 
3. Aims of the Thesis...........................................................................29 
4. Materials and Methods.....................................................................31 
4.1. ELM Bioinformatic Tool......................................................................31 
4.2. Cell Culture........................................................................................31 
4.2.1. Cell Lines and Maintenance Conditions..................................... 31 
4.2.1.1 HeLa Cells..................................................................................... 31 
SACS/UA 2014 
 
2 Cláudia Sofia Nunes Busca 
 
4.2.1.2. CHO Cells..................................................................................... 32 
4.2.1.3. HeLa-CHO co-cultures ................................................................. 32 
4.3. Antibodies..........................................................................................32 
4.4. Cellular Adhesion Assays..................................................................33 
4.4.1. Optimization of CHO-HeLa Adhesion Assays............................ 33 
4.4.2. Antibody Interference Assays..................................................... 34 
4.5. Immunocytochemistry (ICC) Assays.................................................34 
4.6. Immunoprecipitation..........................................................................35 
4.7. Western Blot Assays.........................................................................36 
5. Results.............................................................................................39 
5.1. In Silico Characterization of ZP3 Functional Motifs...........................39 
5.1.1. ZP3 Cleavage Sites.................................................................... 39 
5.1.2. ZP3 Binding Motifs...................................................................... 41 
5.1.3. ZP3 Ligand Motifs....................................................................... 43 
5.1.4. ZP3 Modifications....................................................................... 44 
5.1.5. ZP3 Trafficking............................................................................ 48 
5.2.  Cell-cell adhesion assays………………………............................... 49 
5.2.1. Procedure optimization............................................................. 49 
5.2.2 Characterization of CHO and HeLa Cells Adhesion.................. 53 
5.2.3 Antibody Interference Assays.................................................... 56 
5.3.  Immunocytochemistry Assays……………...................................... 60 
5.4.  Immunoprecipitation Assays……………......................................... 64 
6. Discussion and Conclusions..............................................................................67 
7. References.........................................................................................................73 
Appendix................................................................................................................81 
 
 
 
 
 
 
SACS/UA 2014 
 
Analysis of The Role of ZP3 and APP Cell-Cell Adhesion 3 
 
1. Abbreviations 
aa Amino acids 
Aβ Abeta peptide 
AD Alzheimer’s Disease 
ADAM A Desintegrin And Metalloproteinase 
AICD APP Intracellular Cytoplasmic Domain 
APLPs APP-like Proteins 
APP Alzheimer’s Amyloid Precursor Protein 
CCA Cell-Cell Adhesion 
CFCS Consensus Furin Cleavage Site 
CHO Chinese Hamster Ovary 
CK1 Casein Kinase 1 
CK2 Casein Kinase 2 
CSF Cerebrospinal Fluid 
CuBD Copper-Binding Domain 
DB Dynabeads 
DMEM Dulbelco’s Minimum Essential Media 
DSP Dithiobis(succinimidyl propionate) 
ECM Extracellular Matrix 
EHP External Hydrophobic Path 
ELM Eukaryotic Linear Motif 
FBS Foetal Bovine Serum 
GSK3 Glycogen Synthase Kinase 3 
HGly Heavily Glycosylated 
HMW Heavy Molecular Weight  
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ICC Immunocytochemestry 
IHP Internal Hydrophobic Patch 
IP Immunoprecipitation 
KPI Kunitz Protease Inhibitor 
LB Loading Buffer 
MAPK Mitogen Activated Protein Kinase 
MB Millipore Beads 
NDR N-arginine Dibasic Convertase 
ODf Final Optic Density 
PKA Protein Kinase A 
PKC Protein Kinase C 
PC6B Proprotein Convertase 6B 
PC7 Proprotein Convertase 7 
PI3K Phosphatidyl-Inositol-3-Kinase 
PM Plasma Membrane 
ROI Region Of Interest 
RT Room Temperature 
WB Western Blot 
ZP Zona Pellucida 
ZP-C Zona Pellucida Domain C-Terminus 
ZP-N Zona Pellucida Domain N-Terminus 
ZP1 Zona Pellucida Glycoprotein 1 
ZP2 Zona Pellucida Glycoprotein 2 
ZP3 Zona Pellucida Glycoprotein 3 
ZP4 Zona Pellucida Glycoprotein 4 
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2. Introduction 
Among the various cell-cell interactions that can occur in the body, the 
interaction between the sperm and oocyte germ cells is one of crucial importance 
in species perpetuation. Molecular adhesion can be permanent or transitory, 
maintaining cells in contact with each other or enabling cell signalling, respectively. 
The adhesion events involved in fertilization are mainly transitory. Only the final 
event, the fusion of both gametes culminating in the formation of a zygote, is 
permanent.  Adhesion is a critical event for appropriate oocyte selection within the 
ovary and its transport to the Fallopian Tubes, and to sperm-oocyte binding and 
gamete fusion. Altering adhesion properties can lead to ectopic pregnancies or 
infertility [1]. 
Oocyte activation by sperm is divided into three stages: oocyte-sperm 
recognition and binding; oocyte-sperm fusion; and polyspermy blockage. Following 
ejaculation, the sperm cell will encounter the oocyte when in the female Fallopian 
Tubes, and the recognition between these two cells involves the oocyte’s zona 
pellucida (ZP). ZP is an acellular fibrous and noncollagenous glycoproteinaceous 
matrix that surrounds all mammalian oocytes (Figure 1) [2]–[5] [6]. The name is 
derived from Latin and means transparent belt or girdle. ZP is a porous layer, 
permeable to some macromolecules, such as antibodies [4], [7]. The ability to 
penetrate through is not only dependent on size, but also on the chemical and 
physical characteristic of the molecules [4]. ZP is assembled during the late stages 
of oogenesis when oocytes start to grow, increasing in thickness with oocyte 
development. Their relationship is so close that several studies report that 
production of ZP is crucial for oocyte growth and follicular development [7]. ZP is 
also involved in the binding of sperm during fertilization, being an important 
species-specific barrier, which results in oocyte penetration and leads to gametes 
fusion [5], [8], [9].  
The binding of sperm to the ZP triggers the acrosome reaction of the bound 
sperm cell through the activation of several signal transduction cascades in the 
sperm. The acrosome reaction culminates in the fusion of the acrosome outer 
membrane with the sperm’s plasma membrane, resulting in the exocytosis of the 
acrosome’s contents: protease zymogenes, ZP ligands and other ligand-binding 
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proteins [10]. These enzymes allow the sperm cells to penetrate the ZP and the 
periviteline space, and the sperm must remain bound to the oocyte in order for this 
process to occur. Following this, the sperm and oocyte plasma membranes will 
fuse. The initial contact occurs between the tip of the sperm cell head and the 
oocyte plasma membrane, and then the side of the sperm cell head attaches to 
the oocyte. The fusion is thought to involve the central region of the sperm’s head, 
near the equatorial region [1]. After the fusion occurs, several signalling pathways 
are activated, including an increase in the oocyte intracellular calcium levels. 
These lead to the completion of the oocyte meiosis and to the exocytosis of 
cortical granules from the oocyte, which contain enzymes that alter the ZP matrix 
and block polyspermy [5], [8], [9].  
 
 
 
Figure 1. Schematic image of an oocyte with the nucleus (in blue), perivitelline space 
(white) surrounded by the zona pellucida (orange). 
 
 
2.1. Zona Pellucida (ZP) Glycoproteins 
Human ZP is composed by four glycoproteins: ZP1, ZP2, ZP3 and ZP4 [2]. 
Each consists of a polypeptide chain that is heterogeneously glycosylated with 
mannose and N-acetylglucosamine in the core of N-linked oligosaccharides and 
serine/threonine O-linked oligosaccharides [4]. Human ZP has a unique 
carbohydrate composition very different from other mammalian species [11]. 
Glycosylation has been demonstrated to be crucial for inducing acrosome 
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reaction, especially N-linked glycosylation. However, contrary to previous 
publications, it was found not indispensable for sperm binding [12]. Besides its role 
in sperm-egg interactions, glycosylation is also important for maintaining hydration 
in the matrix [13]. Polylactosamine, fucose and sialic acid residues are also 
present in human ZP. Analysis of the carbohydrate composition of ZP also 
revealed that the more compact area of ZP is closer to the oocyte, and the more 
porous area is in contact with follicular cells, being involved in sperm-oocyte 
interactions. In terms of composition, the porous region accounts for approximately 
25% of the external area of the ZP, whereas the compact constitutes the 
remaining 75% [11]. 
All ZP proteins share a similar structure: a N-terminal hydrophobic signal 
sequence to direct them into a secretory pathway, a ZP domain of approximately 
260 amino acids, a consensus furin cleavage site (CFCS) upstream of a 
transmembrane domain (TMD), which is followed by a short cytoplasmic tail [3], 
[14]. The ZP domain includes 8 conserved cysteine residues and a high β-strand 
content with conservation of polarity and hydrophobicity and turn tendency, which 
precedes the hydrophobic TMD. The ZP domain is present in several other 
extracellular proteins and is involved on protein-protein interactions [15].  
 
2.1.1.  Evolution of ZP Genes 
ZP genes coding for ZP glycoproteins have been divided into six 
subfamilies: zpa/zp2, zpb/zp4, zpc/zp3, zp1, zpax and zpd. Phylogenetic analysis 
suggested that the first event in evolution was a gene duplication, originating zpc’s 
ancestral gene and the precursor of the other subfamilies. In the zpb subfamily a 
gene duplication appears to be responsible for two paralogous genes: zp1 and 
zp4, implying that they had a common ancestral gene. zpb/zp4 is a pseudogene in 
mouse which is a gene that evolved by insertions or deletions that resulted in 
premature stop codons, changing the reading frame and compromising the ability 
to code for a protein. The zpb/zp4 pseudogene in the mouse was originated by a 
microdeletion of 19 nucleotides leading to a frameshift. Similarly, in bovine, zp1 is 
also a pseudogene, resulting from microinsertions and a stop codon in 
chromosome 29. In humans, zpax is a pseudogene located on chromosome 
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2p24.2, resultant of a stop codon in exon 5. Lastly, zpd pseudogenes were 
reported absent from the mammalian genome. The identification of pseudogenes 
implied that evolution of zp genes occurs by death of genes. 
The presence of zp1 in chickens points to a duplication of its ancestral 
before the divergence between birds and mammals. The absence of zpax in 
primates suggests that loss of the gene occurred before the divergence between 
humans and other primates. In mammals, only primates and rodents have zp1, 
indicating that the loss of the gene occurred after the divergence between those 
groups and other mammals.  
The presence of both zpa/zp2 and zpc/zp3 in all the analysed species 
implies a functional importance for the proteins they code for. Overall, this 
suggests that the interaction between sperm and oocyte involves ZPA/ZP2 plus 
ZPC/ZP3, and either ZPB/ZP4 or ZP1, or both [14]. 
Other studies suggest that zp2 and zp3 are rapid evolving genes under 
Darwinian positive selection, emphasising two evolutionary models: the sexual 
conflict model, in which optimal strategies concerning reproduction are conflicting 
between males and females, and the sperm competition model that highlights the 
competition between sperm cells of two different males to fertilize one female [16]. 
The positive selection exerted on them is thought to arise by the selective 
pressure from sperm-egg interactions [17]. 
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Figure 2. A. Phylogenetic tree of zp1, zp2, zp4, zpax and zpd, B. Phylogenetic tree of 
zp3. Genes used for comparisons are shown. The trees were obtained by FIGENIX BLAT 
of porcine ZPA/ZP and ZPC/ZP3 sequences, respectively. Branch length represents rates 
of evolution and values at tree nodes are bootstrap values. Retrieved from Goudet, G. et 
al (2008) [13].  
B 
A 
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2.1.2. Structure and Function of ZP Glycoproteins 
ZP glycoproteins belong to a family of proteins called “zona pellucida 
domain proteins”, a heterogeneous family characterized by the presence of a ZP 
domain in their sequence [18]. This domain is a bipartide structure, with an N-
terminus (ZP-N) and a C-terminus (ZP-C) and two conserved duplicated motifs, an 
internal hydrophobic patch (IHP) between the ZP-N and the ZP-C, and an external 
hydrophobic patch (EHP) further downstream the ZP-C (Figure 3 below) [19], [20]. 
These glycoproteins are known to be produced during the early stages of 
development, but their source is still debatable, having several studies suggested 
that in humans they are synthesized by both the oocyte and follicular cells [4], [9], 
[21]. Taking into account that the oocyte has a low capacity for protein synthesis, a 
role for follicular cells in the production of ZP proteins arose. Moreover, in vitro 
studies have shown that follicular cells are able to produce ZP components [4].The 
synthesis of each protein appears to occur independently despite their coordinated 
gene transcription [13]. Furthermore, synthesis of zona pellucida is thought to be 
associated with their heterogeneous distribution in the matrix and that may be 
associated with sperm penetration [11]. 
Each ZP glycoprotein has its singularities with different amino acid and 
oligosaccharide compositions, precursors, immunological reactivities and 
biological functions [9]. Indeed, despite having amino acid sequences highly 
conserved between vertebrates, their glycosylation patterns are species-specific 
[22].  
 
2.1.2.1. Zona Pellucida Glycoprotein 1 (ZP1) 
 Human ZP1 is a 90-100 kDa glycoprotein composed by 638 amino acids 
[23], [24]. ZP1 has a trefoil domain with six conserved cysteines linked by disulfide 
bonds, upstream of the ZP domain, also present in ZP4 [13]. Early studies in mice 
identified six potential N-linked glycosylation sites in ZP1 [25]. A few studies 
indicated that ZP1 had only a structural function, mediating no interactions 
between oocytes and sperm cells [22]. However, some more recent reports 
suggest that during fertilization ZP1 binds to capacitated sperm cells and its 
glycosylation pattern is important for inducing acrosome reaction [3]. This 
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induction is independent of Gi protein-coupled receptor pathways and involves T-
type and L-type voltage-operated calcium channels (VOCCs) [24]. 
 
2.1.2.2. Zona Pellucida Glycoprotein 2 (ZP2) 
The human ZP2 is composed of 745 amino acids, and in prophase I the full 
length glycoprotein has 105-110 kDa [22], [24]. N-linked glycosylation comprises 
approximately 37% of its mass whereas O-linked glycans reflect only 8% [22]. ZP2 
was implicated in polyspermy blockage. After egg-sperm fusion cortical granules 
are released by the oocyte, where a ZP2-specific protease cleaves the 
glycoprotein in the amino terminal domain, originating a protein with 60-73 kDa. A 
recent study in mice revealed that ZP2 is cleaved by ovastacin, an oocyte-specific 
metalloendoprotease. Indeed, ovastacin was found in cortical granules prior to 
fertilization, but not after. Furthermore, female mice lacking this protease fail to 
cleave ZP2 [26]. The cleavage of ZP2 induces hardening of the oocyte’s zona 
pellucida, and changes in the mechanical properties of the matrix resultant from 
filament compaction, preventing binding of another spermatozoon [19], [23]. 
Furthermore, several studies demonstrate that ZP2 acts as a secondary sperm 
receptor through the biding of its N-terminal to acrosome-reacted spermatozoa, 
facilitating the penetration of the oocyte [27]. Hence, sperm cells cannot bind to 
the cleaved ZP2, blocking polyspermy [23]. Another role that has been attributed 
to ZP2 involves its cooperation with ZP3 in triggering acrosome reaction. The first 
appears to induces the release of Ca2+, facilitating the induction of acrosome 
exocytose mediated by the latter [22].    
 
2.1.2.3. Zona Pellucida Glycoprotein 3 (ZP3) 
ZP3 is by far the most studied of all the ZP proteins. The human zp3 gene 
has approximately 18,3 kbp and contains 8 exons, ranging from 92-312 kbp [28]. 
ZP3 has an N-terminal hydrophobic signal sequence of 22 amino acids, the ZP 
domain, and a tetrabasic CFCS sequence (349RNRR352) upstream of its TMD 
located at the 387-409 amino acids (Figure 3). The mature protein has 12 cysteine 
residues, 8 of each conserved between species, forming four disulfide bonds. The 
ZP domain ranges from the 45 to the 304 residues, its N-terminus is followed by 
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an IHP with 167-173 amino acids and its C-terminus is followed by an EHP with 
362-368 amino acids [29]. 
Human zp3 codes for a glycoprotein with 57-73 kDa and 424 amino acids 
[22], [24]. 27% of ZP3 molecular weight are N-linked oligosaccharides and only 
9% O-linked glycans [22]. Early studies suggested that there was also a truncated 
form of this protein with only 372 amino acids, but this was never confirmed [21]. 
Recombinant ZP3 was shown to trigger acrosome reaction, being suggested as a 
primary sperm receptor [23].  
The role of ZP3 glycosylation remains controversial but has been reported 
as crucial for inducing acrosome reaction, although the polypeptide chain is 
responsible for the binding to spermatozoa [29]–[31]. In humans, acrosome 
reaction mediated by ZP3 is dependent only on N-linked glycans, contrary to what 
occurs in mice, where it is mediated by O-linked oligosaccharides. Recurring to 
inhibitors, it was shown that acrosome reaction is induced by PKC (protein kinase 
C), T-type Ca2+, extracellular Ca2+ and G-protein signalling [30]. Native ZP3 binds 
to the midpiece of intact spermatozoa, being the binding site lost after the 
induction of acrosome reaction [22]. The binding of sperm to ZP3 has also been 
correlated with its stimulatory action on sperm hyperactivation, implying that the 
sperm cells that bind ZP3 (and undergo acrosome reaction) are the motile ones 
[22], [32]. It was also hypothesized that due to the ZP3 unique disulfide linkage 
pattern in the ZP domain, different from other ZPs, the ZP C-terminus is 
responsible for the induction of the acrosome reaction [29]. A study by Baibakov 
and co-workers has provided evidence that binding of sperm to ZP is not sufficient 
for inducing the acrosome reaction, stating the importance of a mechanosensory 
signal produced during the oocyte penetration [22], [33]. 
 
2.1.2.4. Zona Pellucida Glycoprotein 4 (ZP4) 
ZP4 is a 540 amino acids glycoprotein with a molecular weight of 
approximately 65 kDa [22]. This glycoprotein appears to have only N-linked 
glycosylation comprehending 18% of its molecular mass [22], [24]. A few studies 
have demonstrated that human ZP4 is also capable of inducing acrosome 
reaction, having a biding site in the acrosomal region of sperm cells [22], [30], [31]. 
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Similarly to ZP3, acrosome reaction is also triggered exclusively by N-linked 
oligosaccharides and mediated by PKC, T-type Ca2+ channels and extracellular 
Ca2+. Contrary to ZP3, it is independent of G-protein signalling but relies on PKA 
(protein kinase A) and L-type Ca2+ channels [30]. 
 
Crystallography studies shown that there are two types of ZP domain: a first 
found in ZP3, and a second one found in the other ZPs. Its two subdomains, ZP-N 
and ZP-C are separated by a protease-sensitive region [19], [34], [35].  
 
 
  
Figure 3. Schematic representation of ZPs. aa, amino acids; IHP, internal hydrophobic 
patch; CFCS, consensus furin cleavage site; TMD, transmembrane domain; EHP, 
external hydrophobic patch. 
 
 
 
2.1.3.  Secretion and Assembly of ZP Glycoproteins 
The processes of synthesis, secretion and assembly of ZP proteins occur 
simultaneously [35]. Using a mouse model it was possible to study the secretion 
and assembly of these glycoproteins, with their secretion being reported not to be 
uniform [3]. The N-terminal signal peptide directs the precursor to a secretory 
pathway, first starting at the endoplasmic reticulum (ER) where the N-terminal 
ZP1 
ZP2 
ZP3 
ZP4 
638 aa 
745 aa 
424 aa 
540 aa 
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(signal peptide) is cleaved and the protein is folded and modified with high 
mannose type, N-linked oligosaccharides [35]. Then, the protein transits to the 
Golgi apparatus where its O-linked oligosaccharides are added [3], [35], [36]. 
During secretion, but before incorporation into the matrix, the precursor is cleaved 
extracellularly at the plasma membrane by furin-like convertases in its CFCS [20], 
[35]–[37]. The specific enzyme has not been described, but it is thought to be furin, 
PC6B (proprotein convertase 6B) or PC7 (proprotein convertase 7), since they all 
have transmembrane domains upstream of their C-termini, just like ZPs, and co-
localize with these in the secretory pathway, facilitating ZPs cleavage [37]. This 
cleavage process was also validated for human ZP proteins [37].  
 
 
Figure 4. ZP glycosylation pathway and cleavage. Green circles represent N-linked 
glycans and purple squares are O-linked glycans. 
 
 
When oocytes begin to grow, extracellular ZP glycoproteins are organized 
into filaments forming a hexagonal array with a uniform pore (Figure 5). The ZP 
domain is considered essential for their assembly into filaments, being actually 
present in several other proteins that are incorporated into matrices [38]. It is also 
present on uromodulin, α and β-tectorin and in the transforming growth factor-β 
receptor III (TGF-βR3) [39].  
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Upon cleavage within the CFCS there is dissociation of the mature secreted 
peptide and the C-terminus containing the short external hydrophobic patch 
(EHP), between the CFCS and the TMD, which seems crucial for protein secretion 
[19], [20]. Separation between the secreted peptide and the EHP is associated 
with protein activation, inducing polymerization through the ZP domain [19], [20]. 
The IHP also mediates assembly, but appears to have no role in protein secretion. 
Lastly, the TMD is considered essential for propeptide cleavage and assembly, 
although indirectly, and does not seem to be involved in protein secretion [35], 
[38].  
In mice, activation of ZP2 and ZP3 leads to their association into dimers 
that are bound to ZP1 homodimers by dissulfide bounds, forming filaments [9], 
[35]. Hence, ZP filaments are glycoprotein complexes of interspersed homo and 
hetero dimmers [30]. Incorporation of ZP3 into the ZP was also shown to depend 
on the presence of IHP [20]. A few years ago, some studies also showed the 
presence of ZP3-ZP2 dimers, crosslinked with ZP1 and ZP4 in humans [17], [18]. 
When the oocyte increases in size, these pores fuse originating a uniform 
matrix. Concomitantly, there is an increase in the number of microvilli that come in 
contact with follicular cells, establishing communication between them and the 
oocyte. It is thought that ZPs traffic through the oocyte without oligomerization, 
preventing premature assembly [3], [19], [40]. Indeed, ZP2 and ZP3 appear to 
traffic independently inside their secreting cell, and interactions between them are 
only seen after their incorporation into the ZP extracellular matrix [3], [19], [40]. 
ZP2 and ZP3 cytoplasmic tails appear to prevent interactions between them due to 
the hydrophilic nature of their basic amino acid residues [36], [40]. ZPs 
incorporation is believed to occur in the innermost surface of the ZP matrix, 
suggesting that ZP thickens from the inside [3]. ZP can reach a thickness of 13-16 
µm in a mature human oocyte [4]. The mechanism of assembly of the ZP matrix is 
conserved from fish to mammals, suggesting that the conclusions reported from 
mice egg coat studies could be extrapolated to the human ZP [20]. 
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Figure 5. Schematic representation of human ZP filaments. ZP filaments are constituted 
by ZP2 and ZP3 (orange and purple, respectively), interconnected by monomers of ZP1 
and ZP4 (green and red, respectively). 
 
 
2.1.4.  Proteins in Sperm-Egg Interactions 
The interactions between sperm cells and oocytes are still unclear, and 
several models have been proposed: some argue that the gametes interact by 
carbohydrate moieties, others trough protein-protein interactions and finally 
protein-carbohydrate interactions have also been discussed [24]. Of all the 
mentioned above, the most accepted is the latter [3], [12], [29]–[31]. 
For more than 15 years, the prevailing model for sperm-egg binding was 
based on adhesion between an integrin on the oocyte and its ligand on the 
spermatozoon [1]. Integrins are membrane receptor proteins composed of two 
subunits, α and β, and are involved in cellular adhesion [17]. After several studies 
using knockout mice for the α6 integrin subunit, this showed no significant 
reduction in sperm binding, and their role in sperm binding was questioned [1], 
[17]. However, it is possible that their combined complex structures, either than a 
single chain, are responsible for sperm binding [17]. 
Nowadays, several proteins besides ZP glycoproteins are believed to 
participate in the two binding events that take place in sperm-egg interactions [1].  
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2.1.5. Sperm Proteins Involved in Sperm-Egg Interactions 
The ligand of ZP3 present on sperm cells it is still not known, however 
several potential candidates have been proposed, some of them are listed below. 
2.1.5.1. GalT 
GalT is present on the surface of human sperm and of several other 
mammals, which binds to ZP3 through the ZP3 N-acetylglucosamine moiteies. 
Treating purified ZP3 with N-acetylglucosaminidase to remove GalT binding sites 
leads to the loss of the binding ability in sperm, implying GalT as a specific 
substrate of ZP3. In addition, targeted mutations at the galt gene, compromising 
GalT expression and presence in sperm cells, turn these unable to bind to ZP3. 
Furthermore, after fertilization, ZP3 loses the binding sites for GalT, coinciding with 
the loss of binding activity of this glycoprotein in fertilized oocytes. This may result 
from the polyspermy blockage mediated by cortical granules release, since they 
have high levels of N-acetylglucosaminidase. Finally, spermatozoa overexpressing 
GalT have higher rates of G-protein activation and thus, acrosome exocytosis. 
However, information is controversial as some reports show that GalT null mice 
are still able to bind to the zona pellucida, even if at a lesser extent, highlighting 
the hypothesis that N-acetylglucosamine, on eggs, is not the only molecule 
involved in egg-sperm interactions [41]. Alternatively, it was also hypothesized that 
the binding between the oocyte and sperm cells could be mediated by a multimeric 
complex on spermatozoa instead of a single entity [42]. 
2.1.5.2. A Desintegrin and A Metalloproteinase  (ADAM) 
Several ADAMs expressed in male mice germ lines have been implicated in 
fertilization, such as ADAMs 1, 2 and 3. ADAMs were candidate proteins for 
sperm-egg interactions through their desintegrin (integrin-like) domain that would 
bind an egg integrin [43]. In addition to the desintegrin domain, ADAMs also have 
a cystein-rich domain that is followed by an epidermal growth factor repeat, a 
spacer region, a transmembrane domain and a cytoplasmic tail [44]. 
 Contrary to mice, in human and gorilla, the adam1 gene is non-functional, 
presenting deletions, insertions and stop codons. Hence, it was not considered a 
candidate for zona pellucida binding. 
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 ADAM2 (or fertilin β) is a testis specific protein thought to be involved in 
sperm-egg interaction [44]. In fact, knocking out ADAM 2 severely compromises 
sperm-egg binding in mice. Unexpectedly, the deletion of one ADAM resulted in 
loss of several others, which suggests inter-dependency on the regulation of their 
surface expression [43]. In humans, ADAM 2 was shown to bind integrin α6β1 on 
the oolema, mediating sperm-egg interactions [45]. Furthermore, an inhibitory 
study using antibodies demonstrated another protein interacting with ADAM 2 in 
mouse eggs: integrin α9β7. Humans also express this integrin. These results 
support a role of ADAM 2 in sperm-egg interactions [46]. 
ADAM 3, also known as cyritestin, is a testis specific metalloproteinase 
localized in the equatorial region of mice mature sperm cells [41], [44]. The 
equatorial region corresponds to the portion of the plasma membrane involved in 
the initial contact between sperm and oocytes during binding and fusion [44]. 
Targeted deletions of this metalloproteinase resulted in normal sperm migration 
but compromised binding to the zona pellucida [41]. Despite its possible role in 
fertilization in mice, in humans ADAM 3 is a pseudogene, being unable to be 
involved in sperm-egg interactions [44].  
Noticeably, structure-function data suggests that ADAMs could have 
redundant roles, explaining the conflicting data from knock out studies [43]. 
2.1.5.3. Zonadhesin 
Zonadhesin was isolated from pig sperm membranes in 1994 by Hardy and 
Garbers and was associated with species-specificity [47]. It remains the only 
mammalian protein having a validated role in species-specificity. It is produced 
during spermatogenesis and located in the outer acrosomal membrane of 
spermatozoa. In humans, it is only detected in capacitated sperm cells and 
becomes undetectable after acrosome reaction. Zonadhesin shares a common 
structure that is conserved between species; however it is highly variable in amino 
acid sequence. Sperm competition studies show that spermatozoa from 
zonadhesin-null mice were able to bind to the zona pellucida of other mammalian 
species such as pig and rabbit, corroborating previous observations. Targeted 
mutation to zonadhesin did not alter sperm morphology or physiology with only 
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species-specificity being compromised. Of note, proteolytic activity and 
glycosylation are involved in zonadhesin differences between species [47]. 
Since the exposure of zonadhesin occurs after capacitation, this supports a 
recent model for sperm-zona pellucida interactions, in which acrosomal proteins 
influence sperm-oocyte binding [47]. 
2.1.5.4. IZUMO  
Izumo was named after a Japanese marriage shrine. This gene encodes for 
an immunoglobulin (Ig) type I membrane protein with one extracellular Ig domain. 
Recently, the IZUMO family was found to have four members (IZUMO 1 to IZUMO 
4). Near the N-terminus, after the signal peptide and before the Ig domain, there is 
a sequence of high degree of homology between the IZUMO members, being 
designated by the ‘IZUMO domain’. During the acrosome reaction, IZUMO 
translocates from the anterior head of the sperm to the site were fusion occurs 
[48]. The Ig domain of IZUMO 1 has the ability to form dimmers and, in fact, 
complexes of IZUMO 1 and IZUMO 3 were reported in sperm. Despite having a 
well-conserved glycosylation site in the Ig domain, glycosylation was considered 
dispensable for IZUMO 1 function, although it provided protection against its 
fragmentation in the epididymis [48]. IZUMO 1 knock out studies in mice showed 
that it is essential for sperm-egg interactions [46]. IZUMO null mice were healthy 
and had no development abnormalities; males were sterile but exhibited normal 
mating behaviour, and their sperm penetrated the ZP but did not fuse with the 
oocyte. This lead to accumulation of spermatozoon in the perivitelline space [48]. 
 
2.1.6. Oocyte Proteins Involved in Sperm-Egg Interactions 
Besides ZPs, there are other proteins of the oocyte that are thought to 
interact with proteins on sperm cells surface.  
 
2.1.6.1. Integrins 
Integrins are heterodimeric transmembrane proteins involved in cellular 
adhesion [46], [49]. There are 18 α and 8 β subunits, forming 24 different proteins, 
which are divided into five families [46]. Expression of integrin is considered crucial 
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in the early stages of development [50]. In addition, one integrin is able to bind 
more than one ligand. Integrins are not just involved in cellular adhesion but also 
participate in cell signalling, regulating intracellular pH, intracellular Ca2+, inositol 
lipid turnover and protein phosphorylation [51]. After integrin-stimulated adhesion, 
several intracellular pathways are activated, such as MAPK (mitogen-activated 
protein kinase) and PI3K (phosphatidyl-inositol 3-kinase) pathways, involved in 
oocyte activation [51]. Integrin-mediated adhesion or ligand binding can be 
influenced by several factors, including ligand avidity [49]. 
The role of β1 integrin in fertilization remains controversial [49]. Adhesion 
and inhibition studies suggest that β1 integrin on eggs interacts with ADAM 2 on 
sperm [52]. β1 integrin was first reported to increase sperm cells binding rate but 
to be dispensable for sperm-egg fusion and not required for initiation of 
polyspermy blockage [52]. However, others report a significant decrease of sperm-
oocyte fusion after cell treatment with monoclonal antibodies against β1 integrin. In 
addition, it has also been reported the co-localization of β1 integrin oolemal 
patches with fused spermatozoa [49]. Kinetic studies of sperm cell binding from 
WT and β1 null mice imply that β1 integrin helps sperm-egg adhesion. This step 
can be bypassed by attachment to other proteins in a binding-fusion complex [52].  
 
2.1.6.2. CD9 
CD9 is a β1-integrin-associated tetraspanin ubiquitously expressed [48]. 
Tetraspanins are surface proteins composed of four transmembrane domains and 
are able to form complexes with each other and with other membrane proteins, 
forming a “web of tetraspanins”. They can also regulate the molecules with which 
they interact [49]. Blocking antibodies against this protein have been shown to 
inhibit sperm-binding and fusion with ADAM 2 [44]. CD9 knockout mice are healthy 
but females are infertile. CD9 null eggs were unable to fuse with sperm, but since 
they could still bind to the zona pellucida, this resulted in accumulation of sperm in 
the perivitelline space [48]. Rescue experiments, using wild-type and mutant CD9 
mRNA, have highlighted the importance of its large extracellular loop in sperm-egg 
fusion [53]. A large extracellular loop of CD9 was shown to inhibit fusion when pre-
incubated with eggs, but not with sperm cells, implying that CD9 was not a sperm 
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receptor. Since CD9 is able of interacting with several proteins, it was thought that 
it could be modulating the function of a sperm receptor [49].  Overall, these results 
imply CD9 as crucial for sperm-egg fusion [44]. 
A scheme with proteins known to be involved in sperm-egg interaction is 
presented in Figure 6; however, other unreported proteins may be involved in 
these mechanisms, such as APP.  
 
Figure 6. Representation of sperm-egg interactions. Egg proteins believed to interact with 
sperm at different stages are in grey. 
 
2.2. Alzheimer’s Amyloid Precursor Protein (APP) 
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disease and 
the most common cause of dementia [54], [55]. AD is classified into early onset 
(before 65 years of age) and late onset (after 65). The first is also known as 
Familial AD and follows the Mendelian inheritance pattern, with several genes 
being involved, such as app, presenilin 1 (psen 1) and presenilin 2 (psen 2). 
Mutations in these genes result in amyloid beta (or abeta, Aβ) production leading 
to neuron loss and dementia. The late onset forms have also several genes 
associated that give a predisposition for AD, such as apoe, in which the allele ε4 in 
homozygosity is the main risk factor, probably through a change in the protein 
conformation [55].  
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AD pathologic features include extracellular deposits of amyloid fibrils 
designated by senile plaques and intracellular neurofibrillary tangles (Figure 7) of 
hyperphosphorylated Tau. The main component of amyloid plaques is the Aβ 
peptide. This amyloid peptide ranges from 38 to 43 amino acids and is derived 
from a larger protein, the Alzheimer’s amyloid precursor protein, APP [54], [56]. 
 
 
Figure 7. Representation of Alzheimer’s pathologic features. Retrieved from BrightFocus 
Fundation. 
 
APP is a type I transmembrane protein with only one membrane-spanning 
domain, a large extracellular amino terminus and a short cytoplasmic domain [54]. 
The extracellular domain is composed of two subdomains (E1 and E2), 
interconnected by an acidic domain. E1 is divided into growth factor-like domain 
(GFLD) and copper-binding domain (CuBD) [57]. E2 subdomain consists of two 
distinct supercoiled substructures connected by a central helix [57]. This protein is 
ubiquitously expressed in tissues and culture cells. Several functions have been 
attributed to it, such as in cellular adhesion, heparin-binding, cellular growth, 
neuronal excitoprotection, proteinase inhibition, neuronal differentiation [56]. 
 
 
2.2.1. APP Proteolytic Processing 
APP is cleaved by different proteases designated α-, β- and γ-secretases. 
Upon cleavage, a large active peptide is formed, the secreted APP (sAPP). sAPP 
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can be originated by two distinct pathways [54] (Figure 8). The β-secretase 
pathway has been implicated in the pathogenesis of AD. APP undergoes 
proteolysis by an aspartyl protease β-secretase 1 (BACE) producing sAPPβ as 
well as a membrane-bound C-terminal fragment (APP-CTFβ). This is further 
cleaved by γ-secretase releasing Aβ and the APP intracellular cytoplasmic domain 
(AICD) [54]. The α-cleavage pathway is the one mainly activated under 
physiological conditions. α-secretase, which is thought to be a metalloproteinase, 
such as ADAM10 and ADAM9, cleaves APP within the Aβ-sequence, releasing 
sAPPα and a membrane-bound CTF (APP-CTFα). The latter is cleaved by γ-
secretase, generating a truncated Aβ fragment named p3 and AICD. sAPPα is 
present is healthy brains and is associated with physiological functions, such as 
the increase of synaptic density, memory retention, and proliferation of embryonic 
neural stem cells, being considered neurotrophic and neuroprotective [54].  
The APP N-terminus can be also cleaved by another pathway that appears 
to be modulated by protein kinase C (PKC), generating small N-terminal fragments 
(NTFs) of approximately 12-30 kDa. These NTFs, found in human blood and CSF 
(cerebrospinal fluid), appear to play a functional role during neuronal development 
and/or in adult synaptogenesis. [54]. 
 
2.2.2. APP Isoforms 
APP has several isoforms resultant from alternative splicing of three exons 
(7, 8 and 15), generating 8 isoforms (Figure 9) [58]. The isoforms were named 
according to their amino acid length, with the full length APP being designated 
APP 770. This isoform encodes a Kunitz protease inhibitor (KPI) domain in exon 7. 
APP 751 lacks a 19 amino acid sequence in exon 8 that is homologous to MRC 
OX-2. APP 695 lacks exons 7 and 8, and is the most abundant variant in 
mammalian brain. The APP-714 lacks only the KPI domain (exon 7) [59].  
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Figure 8. Proteolytic processing of APP. A. The α-cleavage pathway. B. The 
amyloidogenic pathway. α- and β-secretase cleavage sites are showed by black dotted 
lines and γ-secretase showed by yellow dotted line. 
 
 
Transcripts without the exon 15, which encodes 18 amino acids, were 
initially found in leukocytes and hence designated L-APP [58]. Four L-APP 
variants exist (L-APP 752, L-APP 733, L-APP 696 and L-APP 677), which are 
ubiquitously expressed but quite rare in neurons [59]. The spliced out of exon 15 
generates an isoform that binds through a xylose sugar to a serine and forms the 
core protein of the secreted chondroitin sulfate proteoglycans, termed ‘appicans’ 
[60]. 
B 
A 
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Figure 9. Comparison of the APP isoforms’ structure. KPI, Kunitz Protease Inhibitor 
domain (in E7, exon 7); E8, exon 8; E15, exon 15; CT, cytoplasmic domain. 
 
 
All these isoforms belong to the APP superfamily, which includes APP-like 
proteins (APLPs) (Figure 9). The APP closest protein is APLP2, sharing 46% of 
amino acid sequence (mainly at the protein N- and C-terminus) and, like APP, it is 
ubiquitously expressed [58], [59], [61]. This protein is encoded by chromosome 11, 
whereas APP is encoded by chromosome 21. APLP2 is present in humans, rat 
and mouse, sharing a high homology with APP; however the N-terminus of the 
transmembrane domain is highly divergent, with APLP2 not including the Aβ 
sequence. In fact, Aβ is only present in APP and L-APP [58], [59]. APLP2 also 
lacks APP’s exon 8 but has exon 15 present [58]. APLP1 is encoded by 
chromosome 19, and its expression is confined to the nervous system [61]. It 
shares 35% of homology with full-length APP (770), and the N-terminus of its 
transmembrane domain is again the most divergent region from APP. APLP1 has 
a very similar structure to APLP2 but, contrary to APLP2, APLP1 does not have 
the KPI domain. Both APLP1 and 2 have several isoforms, also generated by 
alternative splicing. Knock out studies with null-mice for APLP1 or 2 or double 
knock out of APP/APLP1 are viable, however knock outs of APP/APLP2 or 
APP 770 
APP 751 PP 751 
APP 795 PP 795 
APP 714 PP 714 
L-APP 
APLP 1 APLP 1 
APLP 2 APLP 2 
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APLP1/2 are lethal. These results imply some functional redundancy that is 
corroborated by structure similarity [61]. 
 
2.2.3. APP Dimerization 
Studies of APP structure suggest it has receptor-like functions. That led to 
the hypothesis of APP dimmer formation and, in fact, it was shown that APP 
undergoes dimerization [61]. The E1 subdomain of APP is the main interface for 
dimerization [57], [61], and deletion of the E2 domain had no effect on this [57]. 
The linker between E1 and E2 also appears to be crucial for dimerization through 
the interaction with E1, allowing its cis- and trans-dimerization (Figure 10) [61]. 
Furthermore, heparin binding to E1 induces homodimerization of APP [62]. 
It is also believed that trans-dimerization is associated with cellular 
adhesion [57], [61]. APP can form homo- and heterodimers between APP, APLP1 
and APLP2, which are involved in molecular adhesion through trans-interaction. 
APP and APLPs are thought to be related to dynamic intercellular processes and 
the accumulation of APP and APLPs in sites of cell-cell interaction indicated their 
direct trans-cellular interactions [57]. Furthermore, heterocomplexes of APP family 
members were found in mice brains, implying a role for cellular adhesion [61]. 
Surprisingly, reports using transgenic mice showed in vivo that the APP/APLP 
interaction is independent of glycosylation [61]. Noticeably, APP and APLP1 and 2 
may have several functions, depending on subcellular location and expression, as 
well as the formation of homo or heterodimers [57].  
Cellular adhesion mediated by molecules such as cadherins is also 
performed by trans-dimerization [61], and N-cadherin also mediates APP 
dimerization [62]. β-1 Integrin is also known to bind APP and mediate its role in cell 
adhesion. Furthermore, it was suggested that a complex of APP and Fe65 could 
regulate integrin signalling in focal adhesions [63]. A relationship between APP 
and β1-integrin was also described in the neuritogenesis process [64].  
 
SACS/UA 2014 
 
Analysis of The Role of ZP3 and APP Cell-Cell Adhesion 27 
 
 
Figure 10. Representation of APP cis (A) and trans-dimerization (B).  
 
 
2.2.4. APP in Sperm Cells 
YWK-II, a truncated form of APLP2, was detected in the equatorial region of 
the spermatozoon’s head, mid-piece and tail. Similarly, APP itself was also found 
in sperm cells. Blocking antibodies against APLP2 were shown to compromise 
fertility in female rats by targeting the interactions between sperm and egg [59]. In 
our laboratory we have shown that full-length APP and/or APLPs are present on 
the surface of the entire spermatozoon, but with particular abundance on the head 
(Figure 11) [59]. All this data suggests that the APP superfamily may have a role in 
reproduction, particularly in sperm interactions with the matrix or the oocyte. 
 
Figure 11. Representation of APP and its isoforms distribution in sperm cells. Taken from Fardilha, 
M. et al (2007) [59] 
204 ANNALS NEW YORK ACADEMY OF SCIENCES
FIGURE 5. Diagrammatic summary representation of the APP superfamily protein
expression in human sperm.
APP superfamily members along the entire length of the tail may be related
to signaling events involved in sperm motility, whereas their presence in the
head and particularly in the equatorial region suggests their involvement in
sperm-oocyte interaction. The elucidation of the precise role of the various
APP family members on sperm function and on fertility will require further
experimentation.
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3. Aims of This Thesis  
Since APP and APLPs are expressed in the plasma membrane of the 
sperm cell’s head, a region involved in sperm-egg interactions, and that ZP3 is the 
primary sperm receptor, it can be hypothesized that APP may mediate interactions 
between those cells. Furthermore, both APP and ZP3 are glycosylated and APP 
undergoes trans-dimerization, implying a role in cellular adhesion, an important 
process in sperm-egg interactions. 
The work here presented aimed to evaluate potential functional and 
physical relationships between ZP3 and APP. Hence, using different cell lines that 
endogenously expressed both proteins, several analyses were performed. 
Thus, the main objectives were: 
 Search for relevant motifs in ZP3 that may relate to APP binding and 
physiology; 
 To evaluate if APP and ZP3 co-function in cell-cell adhesion; 
 To observe if ZP3 and APP co-localize in different cells lines; 
 To test if ZP3 and APP physically interact. 
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4. Materials and Methods 
4.1. ELM Bioinformatic Tool 
 “The Eukaryotic Linear Motif resource for functional sites” (ELM) was used 
to analyse functional motifs present in the ZP3 amino acid sequence. This 
software is designed for detection of functional motifs within an amino acid 
sequence and is freely available in (http://elm.eu.org/). Functional sites were 
detected using regular expressions (patterns) through a logical filter to discriminate 
between true matches and false positives. This software uses PHI-BLAST to map 
predictions concerning a specific sequence, and the mapping is performed by 
sequence similarity and motif conservation. The localization of these sequences 
has implications for their function. Taking into account that these sequences have 
to be recognized by other proteins they have to be structurally accessible and in 
the same cellular compartment. ELM has several filters such as taxonomic range 
filter, cell compartment filter, structure filter, globular domain filter and the 
probability filter. This software provides information about functionally relevant 
sequences, mapping their location, describing them, placing them in a cellular 
compartment, providing a pattern with an associated probability. Patterns with low 
probabilities are regarded as regular expressions, whereas those with higher 
probabilities have a more degenerate expression. 
4.2. Cell Culture 
4.2.1. Cell Lines and Maintenance Conditions 
4.2.1.1. HeLa Cells 
In the impossibility of performing sperm-egg interaction assays in our 
laboratory, immortalized cell lines were used to study the role of ZP3 and APP in 
cell-cell adhesion. The HeLa mammalian cell line was used, since according to 
The Human Protein Atlas (www.proteinatlas.org) it has a good expression of 
endogenous ZP3 and APP, it is a highly adhesive cell line, and is routinely used in 
the lab. HeLa cells are an immortalized cell line originated from cervical cancer 
cells. These were originally collected from a cancer patient named Henrietta 
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Lacks. HeLa cells were maintained in Dulbeco’s Minimum Essential Media 
(DMEM; Gibco) supplemented with 10% foetal bovine serum (FBS; Gibco), 100 
IU/mL of penicillin, 100 µg/mL of streptomycin and 25 µg/mL of amphotericin B 
utilizing penicillin G (Life Technologies). Cells were incubated at 37ºC in 5% Co2 
and were subcultured when 90% confluence was reached. 
4.2.1.2. CHO Cells 
Chinese hamster ovary cells (CHO-K1; ATCC number: CCL6) were also 
used due to their ovary nature. CHO were cultured in Ham’s F-12 nutrient mixture 
(Sigma-Aldrich) containing 2 mM L-glutamine, 10% FBS (Gibco), 100 IU/mL of 
penicillin, 100 µg/mL of streptomycin and 25 µg/mL of amphotericin B utilizing 
penicillin G (Life Technologies). Cells were incubated at 37ºC in 5% CO2 and 
subcultured when 90% confluence was reached. 
4.2.1.3. HeLa-CHO co-cultures  
When indicated, HeLa and CHO cells were co-cultured at 50-60% 
confluence in six-well plates (immunocytochemistry assays), or at 100% 
confluence in 100 mm plates (immunoprecipitation assays), in the CHO cells 
medium.  
4.3. Antibodies 
The primary antibodies used in this work were the polyclonal ZP3 rabbit 
antibody from Proteintech (21279-1AP), the monoclonal 22C11 anti APP N-
terminus mouse antibody (Chemicon), directed against APP N-terminus, the 
polyclonal anti-APP CT695 (Invitrogen) directed against APP C-terminus, and 
antibodies against beta1-Integrin: total beta1-Integrin MAB1981 antibody 
(Millipore) and a function blocking beta1-Integrin MAB1959 antibody (Millipore). 
 Polyclonal ZP3 rabbit antibody recognizes the N-terminus of human ZP3 
and detects several glycosylated forms of this protein (e.g. 47kDa and ≈ 92kDa). 
The 22C11 and CT695 APP antibodies both recognize full length APP O- and N- 
and O-glycosylated forms (≈100kDa and 130kDa).  
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Table 1. List of antibodies used in cell-cell adhesion (CCA), immunocytochemistry (ICC), 
immunoprecipitation (IP), and western blot (WB) assays, with respective dilutions. 
 
 
4.4. Cellular Adhesion Assays 
4.4.1. Optimization of CHO-HeLa Cells Adhesion Assays 
Cell-cell adhesion assays were undertaken based on Zepeda-Moreno et al 
(2011) [65]. In a 96-well plate, a feeder layer of 15 000 HeLa cells was plated and 
incubated overnight at 37ºC in 5% CO2. In the following a day the feeder layer had 
reached confluence. Then, different number of HeLa and CHO cells (between 104 
and 105 cells, indicated in each assay) were plated over the feeder layer or directly 
on the plate plastic bottom. Following, plates were incubated for 1h at 37ºC in 5% 
CO2, after which the plate was inverted and cells incubated for 1,5 hours at 37ºC 
in 5% CO2. Then, with the plate tilted at 45-70 degrees, the non-adherent cells in 
the supernatant were collected with a micropipette to an empty 96-well plate. With 
an end-volume of 100 µL of cells, 10 µL of resazurin (0.1 mg.mL-1 resazurin in 
phosphate buffer saline (PBS) [Pierce, Perbio, Thermo Scientific, Bonn, 
Germany]) were added and incubated overnight at 37ºC in 5% CO2. In the 
following day cells were indirectly evaluated via the spectrophotometrically 
Name Epitope Assay Secondary Antibody 
ZP3 
N-terminus of 
ZP3 (52-251 aa) 
CCA (1:100) 
ICC (1:100) 
IP (1:1000), 
WB (1:500) 
Horseradish Peroxidase 
conjugated (1:5000) or  
Fluorophore-conjugated (1:300) 
α-Rabbit IgGs  
22C11 
N-terminus of 
APP 
IP (1:20), 
WB (1:250), 
ICC (1:50) 
Horseradish Peroxidase  
conjugated (1:5000) or  
Fluorophore-conjugated (1:300) 
α-Mouse IgGs 
C-Ter 
C-terminus of 
APP 
IP (1:100) - 
Beta1-
Integrin 
MAB1959 
non described CCA (1:100) - 
Beta1-
Integrin  
MAB1981 
Beta1 Integrin 
588-706 aa 
sequence  
ICC (1:100) 
Fluorophore-conjugated (1:300) 
α-Mouse IgGs 
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quantification (at 570 and 600 nm) of the conversion of resazurin to resorufin by 
metabolically active cells using the Infinite M200 microplate reader (Tecan). A final 
optical density (O.D.f) was determined for each sample: (O.D.570/O.D.600)- 
(O.D.570c/O.D.600c); ‘c’, O.D. of control samples (medium only plus resazurin). 
 
4.4.2. Antibody Interference Assays 
In a 96-well plate, following the protocol described by Zepeda-Moreno [65], 
a feeder layer of 15 000 HeLa cells per well was plated and incubated overnight at 
37ºC in 5% CO2. In the following day, the cells in the feeder layer were confluent. 
Before seeding, the top and/or the bottom (feeder) layer were treated with 
specific antibodies against APP, ZP3 or beta1-integrin. Top layer: CHO cells were 
washed with PBS, collected, and counted in a haemocytometer using Trypan blue 
as a vital dye. Cells were centrifuged for 3 min at 1000 g, and ressuspended in 
100 l of 3% BSA in PBS in a sterile microtube. The respective blocking antibody 
(Table 1) was added, and cells incubated for 1h at 4º C, with orbital agitation. Cell 
medium was added, and cell number-normalized aliquots were plated as 
described above. The experiments were performed in triplicate.  
 
4.5. Immunocytochemistry (ICC) Assays 
To determine if ZP3 and APP co-localize in mammalian cells and their sub 
cellular localization, immunocytochemistry assays were performed in CHO cells 
cultures, HeLa cells cultures, and in CHO-HeLa cells co-cultures. The co-
localization of ZP3 with beta1-Integrin was also evaluated. 
On a 6-well plate, HeLa cells, CHO cells, or a HeLa-CHO co-culture were 
plated on coverslips and cultured until 50-60% confluence at 37ºC in 5% CO2. 
Cells were washed twice with PBS and fixed in 4% paraformaldehyde in PBS for 
20 minutes. Following, cells were washed with PBS three times, 10 minutes each. 
After removal of the PBS, cells were permeabilized with 0,2% TRITON in PBS 
solution at room temperature (RT) for 10 minutes. Cells were washed three more 
times with 1x PBS for 10 minutes each. Then, these were blocked in a 
3%BSA/PBS solution for 30 minutes at RT and then washed with PBS for 5 
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minutes. Cells were incubated with the anti-ZP3 and anti-APP 22C11 primary 
antibodies (respective dilutions are present in Table 1) for two hours and then 
washed three times with PBS for 10 minutes each. The secondary antibodies anti-
rabbit Alexa Fluor 594® (1:300; Molecular Probes®, Life Tecnhologies) and anti-
mouse Alexa Fluor 488® (1:300; Molecular Probes, Life Technologies) were 
incubated with the cells for 1 hour in the dark. The coverslips were further washed 
three times with PBS and one last time with distilled water, and then mounted with 
the DAPI-plus VECTASHIELD® mounting media (Vector Laboratories) on 0.1 mm 
microscope glass slides for epifluorescence (Olympus IX-81 motorized inverted 
microscope) and confocal microscopy analyses [LSM 510 META confocal 
microscope (Zeiss, Jena, Germany; equipped with an Argon laser of 488 nm 
(green channel), a 561 nm DPSS laser (red channel) and a Diode 405-430 laser 
(blue channel)]. 
 
4.6. Immunoprecipitation (IP) 
To determine if ZP3 and APP physically interact, immunoprecipitation 
assays were performed. Plates of 100 mm of confluent cultures of HeLa cells, 
alone or co-cultured with CHO cells, were used. The antibodies used were the 
anti-ZP3 and the anti-APP CT695 antibodies (dilutions used are in Table 1). 
When indicated, a crosslinker solution with dithiobis(succinimidyl 
propionate) (DSP; Thermo Scientific) was used to stabilize the interaction. In these 
assays, the cells medium was aspirated, cells were washed two times with PBS, 
and 750μl-1 ml DSP cross linker (0.4 mg DSP/ml PBS) was added and cells 
incubated for 45 min at RT. After adding the crosslinker, cells were placed on ice 
and washed with a solution of PBS and PMSF (diluted 1:100). Cells were further 
collected from the 100 mm plates with plastic scrappers (Greiner) into microtubes. 
All samples were centrifuged at 3000 g for 5 minutes at 4 ºC. After removing the 
supernatant, 600 µL of lysis buffer was added to each sample. During the 30 
minutes of lysis, lysates were for three times pipetted up and down to ensure 
proper cellular lysis. In the meantime, magnetic beads coupled with sepharose G 
(dynabeads from Life Technologies, or magnetic beads from Millipore) were 
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washed in 3% BSA/ 1% PBS three times and kept in the same solution. After 
cellular lysis, the samples were centrifuged at 20 000 g for 5 minutes at 4 ºC, and 
the supernatant was collected. To an aliquot of 40 µL of the lysates supernatant, 5 
µL of 10% SDS (sodium dodecyl sulphate) and 15 µL of 4x loading buffer (LB) 
were added, and the aliquots boiled at 90ºC for 10 minutes and kept at 4ºC. The 
remaining supernatant sample was pre-cleared by incubation with 9 µL of beads 
for 1 h at 4 ºC with orbital agitation. To each pre-cleared supernatant, 30 µL of the 
pre-washed sepharose G bead were added, together with the respective 
antibodies (antibody dilutions are present in table 1). The immunoprecipitation was 
left to occur overnight at 4ºC with orbital agitation.  
On the following day, the microtubes were placed on the magnet and the 
supernatant was discarded. The beads were first washed with 500 µL of a 
3%BSA/1x PBS solution, with orbital agitation for 5 minutes at 4ºC. The 
microtubes were placed again on the magnet, the washing buffer (supernatant) 
was discarded, and the beads washed four times with PBS, for 10 minutes each, 
with orbital agitation at 4ºC. After removing the last supernatant, 100 µL of 
LB/1%SDS was added. The samples were then boiled at 90ºC for 10 minutes prior 
to being subject to western blot. The experiments were performed in duplicate. 
 
4.7. Western Blot Assays 
After the IP assays, lysates and IPs were subjected to 6.5 or 7.5% sodium 
dodecylsulfate polyacrilamide (SDS) gel electrophoresis (PAGE), after which the 
resolved proteins in the gel were electrotransferred onto nitrocellulose 
membranes. After transfer, membranes were hydrated in 1x TBS for 10 minutes, 
and blocking solution was added for 1h (5% non-fat dry milk in 1x TBS-T), to block 
non-specific binding sites. Primary antibody, diluted in 3% non-fat dry milk in 1x 
TBS-T, was added and incubated with membranes overnight. The membranes 
were further washed three times with 1x TBS-T for 10 minutes each, after which 
they were incubated with the respective secondary antibody, diluted in 3% non-fat 
dry milk in 1x TBS-T, for 2h with agitation. All antibody dilutions are present in 
table 2. Membranes were finally washed three times with 1x TBS-T for 10 minutes 
each. 
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The detection of the secondary antibody was carried out using the 
enhanced chemiluminescence (ECL) detection method. After the washes, 
membranes were incubated with 1 mL of Luminata™ Crescendo (Millipore) for 3-5 
minutes. Inside a dark room, sheets of Hyperfilm ECL (GE Healthcare) were 
placed over the membranes in an x-ray cassette. After the appropriate time of 
exposure, the film was developed in a developer solution (Sigma Aldrich), washed 
in water and fixed in a fixation solution (Sigma Aldrich). Membranes were then 
washed three times with 1x TBS-T and left to dry. The films were scanned in a 
GS-800 calibrated imaging densitometer (Bio-Rad) and bands were scanned using 
Quantity One Software (Bio-Rad). 
 
 
  
SACS/UA 2014 
 
38 Cláudia Sofia Nunes Busca 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SACS/UA 2014 
 
Analysis of The Role of ZP3 and APP Cell-Cell Adhesion 39 
 
5. Results 
 
5.1. In Silico Characterization of ZP3 Functional Motifs 
The functional motifs of the ZP3 amino acid sequence were first analysed 
using the “Eukaryotic Linear Motif” (ELM) bioinformatics tool, to unravel potential 
motifs involved in binding to APP or to known APP binding partners, or motifs 
involved in pathways common to APP.  
After entering the human ZP3 amino acid sequence, the software displayed 
results for globular/ transmembrane domains and signal peptide length detected 
using SMART (Simple Modular Architecture Research Tool) tool. The provided 
signal peptide is composed of 19 amino acids, very similar to the 22 reported in 
the literature. Similarly, the ZP domain proposed has 258 amino acids (45-303), 
also very close to the published results (45-304) [29]. 
 
5.1.1. ZP3 Cleavage Sites 
ELM found three ZP3 cleavage sites: N-arginine dibasic convertase (NDR) 
cleavage site, furin cleavage site and proprotein convertase 1 (PCSK 1) cleavage 
site (Figure 11). 
 
NRD Cleavage Site 
NRD convertase is a metalloendopeptidase of the M16 family involved in 
protein processing. It can be found extracellularly, at cell surface or in the Golgi 
apparatus. This enzyme cleaves proteins at the N-terminus of arginine (Arg) 
residues in dibasic motifs (Arg-Arg or Lys-Arg). It has been shown to cleave α-
neoendorphin, dynorphin, preproneurotensin and somatostatin. This enzyme has 
two isoforms, NRD 1 and NRD 2. They differ on a 68 aa sequence close to the 
active site present only in NRD 2, which can have implications in its function. 
Northern blot analyses have shown that NRD 2 represents 50% of transcripts in 
human testis. It can also be found in the cytoplasm of elongated spermatids and 
has been associated with sperm cell differentiation during spermatogenesis [66]. 
Besides those tissues, NRD was present in brain cortex of rats [67]. 
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ELM found two regions in ZP3 potentially recognized by NRD 1 convertase: 
RRQ (334-336) and RRH (351-353). Both sequences have a low probability 
(approximately 0.007) for the same pattern (.RK)|(RR[^KR]). This patter implies 
that for the first position any amino acid is allowed, in the second an arginine is 
present and in the third a lysine; or in the first two positions arginines are present 
but in the third either a lysine or an arginine are not allowed (see table 2 for the 
characters used to describe the motifs’ patterns). 
 
Table 2. List of characters present in patterns detected by ELM (Adapted from elm.eu.org) 
 
Character Name Meaning 
. Dot Any amino acid allowed 
[...] Character Class Amino acids listed are allowed 
[^…] Neglected Character 
Class 
Amino acids listed are not allowed 
(min, max) Specific range min, required; max, allowed 
| Alternation Matches either expression it 
separates 
() Parenthesis Used to mark separate parts of 
the expression 
 
Furin Cleavage Site 
Furin is a serine endoprotease and a member of the subtilysin-like family, 
which is a family of pro-protein convertases. Similar to NRD, furin also cleaves 
dibasic residues of precursor proteins. Furin is can be found extracellulary, in the 
Golgi apparatus and at the membrane. Furin consensus cleavage site is present in 
growth factors and receptors, serum proteins and viral envelop proteins [68].  
The software found one sequence in ZP3 identified by furin, RNRRH (349-
353), what may occur extracellularly, in the Golgi apparatus and membrane. The 
proposed pattern is R.[RK]R. with a probability of approximately 0.0005. The first 
position has an arginine, the second allows any amino acid, the third allows either 
arginine or lysine, the fourth has an arginine, and the last allows any amino acid. 
Furin also recognizes similar sequences in other proteins, such as glycoproteins in 
viral envelopes of Ebola and Human T-cell leukemia virus 2 (HTLV-2). 
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Subtilisin/Kexin-Isozyme 1 (SKI 1) Cleavage Site 
Like furin, SKI 1 is an endoprotease and member of the subtilisin-like family. 
SKI 1 is also involved in protein processing at basic residues. This enzyme can be 
found in the lumen of the endoplasmic reticulum, in the Golgi and extracellularly 
[69]. SKI 1 is involved in the proteolytic processing of several proteins such as viral 
proteins of Hepatitis C virus (HCV) that control cholesterol metabolism [70]. 
ELM showed a motif in ZP3 identified by SKI 1: RHVTE (352-356). The pattern 
proposed for this sequence was [RK].[AILMFV][LTKF]. with a probability of 
approximately 0.007. The pattern allows either an arginine or a lysine for the first 
position; in the second any amino acid is allowed, in the next alanine, isoleucine, 
leucine, methionine, phenylalanine and valine; in the fourth, leucine, threonine, 
lysine and phenylalanine are allowed. 
 
Figure 12. Representation of ZP3 cleavage sites, showing both sites recognized by NRD, 
one site recognized by SKI 1 and one site recognized by furin (in red). 
 
 
5.1.2. ZP3 Binding Motifs 
This software identified two binding motifs in ZP3: USP 7 binding motifs and 
WW binding motifs. 
USP 7 Binding Motif 
USP 7 is a deubiquitinating enzyme, also known as HAUSP. It has four 
domains, a N-terminus domain, a catalytic domain and two C-terminal domains. 
This enzyme cleaves ubiquitin from substrates, preventing protein targeting to the 
proteasome for degradation and increasing the pool of free ubiquitin trough 
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ubiquitin recycling. USP 7 is present in the nucleus and mediates deubiquitination 
of P53 and Mdm2 [71]. 
ELM reported three motifs in ZP3 recognized by USP 7: PETSV (35-39), 
PSNSW (305-309) and PSHSR (330-334). The associated pattern has a 
probability of approximately 0.01 for [PA][^P][^FYWIL]S[^P], in which the first 
position allows a proline or an alanine, the second excludes proline, the third 
excludes phenylalanine, tyrosine, tryptophan, isoleucine and leucine; the fourth 
position has a serine and the last position only excludes proline.  
Besides ZP3, other proteins have a USP 7 binding motif, such as human 
Mdm2 and human p53, corroborating previews publications [71]. Additionally, 
human Mdm4 was also proposed by ELM to share a USP 7 binding motif. 
WW Binding Motif 
WW domains are named after the two tryptophan residues crucial for their 
activity, and consist of small regions of 38 to 40 amino acids in a β-sheet [72]. This 
module is one of the smallest that is able to fold as a monomer without disulfide 
bonds or cofactors. Proteins with this domain are divided into two major and two 
minor groups: Group I, one of the major groups, binds polypeptides with the 
consensus sequence PPxY; Group II, also a major group, bind peptides with PPLP 
motif; the third group binds to proline-rich motifs flanked by R or K and the last 
group (IV) binds to short phosphoserine or phosphothreonine followed by a proline 
[73]. Proteins with this motif are involved in protein-protein interactions trough 
binding of proline rich motifs. In addition, this domain also plays a role in cell 
signalling [72]. In the nucleus it was shown to participate in the co-activation of 
transcription and modulation of RNA-polymerase II activity. The WW domain has 
been implicated in several human diseases, including AD [73]. 
ELM found one WW domain motif, DCGTPS (326-331) and proposes that 
binding to this motif occurs in the cytosol and in the nucleus, as referred in the 
literature [73]. The pattern ... [PV]..P has a probability of approximately 0.02, in 
which the first three positions allow any amino acid, the following allow only a 
proline or an arginine the next two allow any amino acid and the last has a proline 
(see table 3). The WW domain motif was also found in several other proteins in 
humans besides ZP3, such as α-globin transcription factor, synphilin 1, p53, p73 
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and beta-catenin. This motif is also present in Fe65, which is binds the 
cytoplasmic domain of APP, interfering with its the proteolytic processing, 
regulating the function and availability of APP at cell surface [63]. 
 
 
Figure 13. Representation of ZP3 binding motifs, three USP7 binding motifs are 
highlighted as well as one WW binding motif. 
 
 
5.1.3. ZP3 Ligand Motifs 
ZP3 has a ligand motif recognized by SH3 domains and a TRAF2 binding 
consensus motif. 
SH3 Ligand Motif 
SH3 (Src homology 3) domains are small modules of approximately 50-60 
residues. This domain usually binds proline residues and is involved in protein-
protein interaction, cytoskeleton rearrangement, membrane traffic and organelle 
assembly.  
The software found a sequence on ZP3 for SH3 domain WFPVEGP (309-
315) and suggests that ligand binding to this domain occurs in the plasma 
membrane, focal adhesion and/or cytosol. The pattern ...[PV]..P had an 
approximate 0.01 probability, where the first three positions allow any amino acid, 
the fourth is either a proline or a valine the following two allow any amino acid and 
the last has a proline (see table 3). The sequence present on ZP3 was also found 
in p73, T-cell antigen CD2, dystroglycan and Tau protein in humans, the latter 
being an important protein in AD. 
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TRAF2 Binding Motif 
Tumour necrosis factor receptor-associated factors (TRAFs) belong to a 
family of adaptor proteins which share a common domain in the C-terminus. This 
region allows interaction with cell receptors and other molecules. TRAF has 
several isoforms. TRAF2 is a 56 kDa protein and is involved in protein-protein 
interactions and in cell signalling, playing a role in NF-КB activation [74]. 
ELM reported a TRAF2 binding motif in ZP3: PGQE (368-371). The binding 
of TRAF2 was reported to occur in the cytosol. The pattern [PSAT].[QE]E has a 
probability of approximately 0.004, the first position has a proline, a serine, an 
arginine or a threonine; the second position allows any amino acid, the third has a 
glutamine or a glutamate and the last position has a glutamate. This motif was 
also found in other proteins, such as TNF 9, CD 27 and TNF 8. 
 
 
Figure 14. Representation of ZP3 ligand motifs. SH3 and TRAF2 binding motifs are 
shown 
 
 
 
5.1.4. ZP3 Modifications 
ZP3 undergoes post-translational modifications, such as phosphorylation 
and glycosylation. ELM reported several sites in ZP3 that are recognized by 
several enzymes: CK1 and CK2 phosphorylation sites, glycosaminoglycan 
attachment site, GSK3 phosphorylation sites, PIKK phosphorylation site, PLK 
phosphorylation sites and proline-directed kinase phosphorylation site. 
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CK1 and CK2 Phosphorylation Sites  
Casein kinase 1 (CK1) and 2 (CK2) belong to a family of serine/threonine 
protein kinases involved in signal transduction pathways in a wide range of 
organisms, from yeast to humans. The CK1 family in humans is composed by 
seven enzymes, which play an important role in Wnt signalling, circadian rhythms, 
nucleo-cytoplasmic shuttling of transcription factors, DNA repair and transcription 
and glycogen metabolism [75]. CK1 is ubiquitously expressed and has been 
associated with several diseases, including AD, where it has been proposed as a 
candidate kinase in tau hyperphosphorylation [76]. CK2 is involved in cell growth 
and proliferation as well as suppression of apoptosis. This enzyme can use both 
ATP and GTP as a substrate and its main determinant is its specificity towards a 
negative charge three positions after the modification residue. Knock out studies in 
mice emphasized the importance of CK2 for cell survival [77]. 
ELM found one phosphorylation site for CK1 in ZP3: SQWSTSA (341-347) 
and another for CK2, GGASHPE (30-36). Both kinases can be found in the 
nucleus and in the cytosol and CK2 can also be present in the CK2 complex. The 
software found the pattern S..([ST])... with a probability of approximately 0.02 for 
CK1 and for CK2 the pattern ...([ST])..E with a probability of approximately 0.01. In 
the first case, the first position is a serine, the following two allow any amino acid, 
the fourth allows either a serine or a threonine and the last three allow any amino 
acid.  The second pattern allows any amino acid for the first three positions, the 
fourth allows a serine or a threonine, the following two positions allow any amino 
acid and in the last position is a glutamate. The sequence corresponding to the 
CK1 phosphorylation site was also found in two other human proteins: p53 and 
YAP1. The sequence recognized by CK2 present on ZP3 is also present in human 
PTEN, DNA repair protein XRCC1 and HIV1. 
Glucosaminoglycan Attachment Site 
Glucosaminoglycans are polysaccharides involved in physiological 
functions, such as blood coagulation, cell growth, communication, and 
morphogenesis [78]. These are ubiquitously expressed in mammals and their 
sulfation pattern has severe implications in their ability to interact with other 
molecules [78], [79].  
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ELM reported one glucosaminoglycan attachment site: TSAS (345-348), 
with this binding occurring in the Golgi apparatus or extracellularly. The pattern 
found was [ED] {0,3}.(S)[GA], with a probability of approximately 0.02, where the 
first position allows a glutamate or an aspartate with a maximum of three of these 
residues, the second position allows any amino acid, the third has a serine and the 
last allows a glutamine or an alanine. Proteoglycans with glucosaminoglycan 
moieties are very important in the extracellular matrix (ECM), since besides 
structural properties, the addition of these moieties enables the proteoglycan to 
exert space-filling and lubrication functions in the matrix. Furthermore, the binding 
functions ascribed to proteoglycans is thought to be involved in the regulation of 
protein complexes in the ECM [80].  
GSK3 Phosphorylation Site 
Glycogen synthase kinase 3 is a constitutively active serine/threonine 
kinase that is ubiquitously expressed, with high levels of expression in the brain. It 
is involved in cellular metabolism, cell cycle regulation, gene expression, 
development and neuroprotection. GSK3 has a wide variety of substrates, such as 
glycogen synthase and β catenin. This kinase has been implicated in the 
pathogenesis of several diseases, like AD, diabetes, cancer, and inflammation 
[81]. Noteworthy, the AICD fragment of APP is known to bind Fe65 and, upon their 
nuclear targeting, to enhance gsk3β expression [82]. 
ELM found five GSK3 phosphorylation sites in ZP3: GGASHPET (30-37), 
DCGTPSHS (326-333), HVMSQWST (338-345), SQWSTSAS (341-348) and 
ADVTVGAT (358-365). Phosphorylation of ZP3 can occur in the cytosol and in the 
nucleus. The pattern ...([ST])...[ST] has an approximate probability of 0.03. The 
first three positions allow any amino acid, the forth allows for either a serine or a 
threonine, the following three allow any amino acid and the last allows a serine or 
a threonine. The sequence found by the software is also present in many other 
human proteins, such as p53, ataxin 3, zinc finger protein SNAI 1, SMADs 1 and 
3, MYC. 
MAPK Phosphorylation Site 
Mitogen-activated kinases (MAPK) are essential players in signal 
transduction networks. These kinases recognize serine/threonine residues 
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followed by a proline. Dysregulation of MAPK pathways are associated with 
diseases such as cancer, developmental diseases, neurodegenerative diseases 
and metabolic diseases [83]. An APP-MAPK relation is currently being 
investigated in our laboratory (data not published).  
ELM found one MAPK phosphorylation site in ZP3: DCGTPSH (326-332). 
Phosphorylation of ZP3 by MAPK can occur in the nucleus and in the cytosol. The 
pattern ...([ST])P.. was found with a probability of approximately 0.02. The first 
three positions allow any amino acid the fourth allows either a serine or a 
threonine, the following has a proline and the last two allow any amino acid. The 
short motif found by ELM is present in many other proteins, such as the human 
retinoic acid receptor α, transcription factors ETV6 and SP1, Myc and HIF1. 
 
 
Figure 15. Representation of ZP3 modification sites. CK1, CK2, GSK3, PIKK, PIk and 
MAPK phosphorylation sites are shown. Glycosaminoglycan attachment site is also 
shown. CK1, casein kinase 1; CK2, casein kinase 2; GSK3, glycogen synthase kinase 3; 
PIKK, hosphoinosidite-3-OH-kinase related kinase; Plk, polo-like kinase; MAPK, mitogen-
activated kinase. 
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5.1.5. ZP3 Trafficking 
di-Arginine Retention/Retrieval Signal 
Di-Arginine-based endoplasmic reticulum (ER)-localization signals are 
motifs involved in the transport of multimeric proteins and consist of two arginine 
residues next to each other. These signals can direct a broad range of proteins to 
the ER and retain them there, but direct mainly membrane protein complexes. In 
several cases, a di-leucine endocytic or lysosomal targeting signal is also present 
near di-arginine targeting motifs. Arginine signals can also participate in the 
regulation of receptor-complex assembly. Contra intuitively, only a minority of 
proteins with arginine-based signals undergo any modification in the ER. [84]. 
ELM found one arginine-based signal in ZP3: RNRR (349-352). The 
software reported the pattern ([LIVMFYWPR]R[^YFWDE] {0,1} R) | (R[^YFWDE] 
{0,1} R[LIVMFYWPR]) with a probability of approximately 0.005. In this case the 
pattern has two possible expressions. The first allows leucine, isoleucine, valine, 
methionine, phenylalanine, tyrosine, tryptophan, proline and arginine in the first 
position; the second position has an arginine, the third position excludes tyrosine, 
phenylalanine, tryptophan, aspartate and glutamate or at least one of them, the 
last position has an arginine. The second condition allowed, has an arginine in the 
first position, excludes tyrosine, phenylalanine, tryptophan, aspartate and 
glutamate, or at least one of them; the third position is an arginine and the last 
allows a leucine, a isoleucine, a valine, a methionine, a phenylalanine, a tyrosine, 
a tryptophan, a proline and an arginine. The sequence found by ELM in ZP3 is 
also present in many other proteins, such as human NMDA1, ABCC8, GPR15 and 
ADAM10. 
Endosome-Lysosome-Basolateral Sorting Signals 
Several membrane proteins have leucine-based motifs in their cytoplasmic 
domain to facilitate their internalization. There are two types of motifs, one that is 
dependent on phosphorylation and another with an acidic amino acid residue 
which is constitutively active. It was proposed that the position of these motifs 
within the cytoplasmic domains of receptors may influence their activity at the 
trans-Golgi network and at cell surface [85]. 
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ELM found one endocytic sorting signal in ZP3: QPLWLL (23-28). The 
pattern [DERQ]...L[LVI] had an approximate probability of 0.003, where the first 
position has an aspartate, a glutamate, an arginine or a glutamine; the following 
three positions allow any amino acid, the fifth has leucine and the last allow a 
leucine, a valine and an isoleucine. The sequence reported by ELM is also present 
in many other proteins as is the case of human CD4, CD74, CD44 and ATP7A. 
 
 
 
Figure 16. Representation of ZP3 trafficking sites. di-Arginine retention/ retrieval signal 
and endosome-lysosome-basolateral sorting signal are shown. Endo-Lys-Bas, endosome-
lysosome-basolateral sorting signal; di-Arginine, di-Arginine retention/retrieval signal. 
 
 
 
 
5.2. Cell-cell adhesion assays  
5.2.1. Procedure optimization 
Since this was the first time this procedure was used in the laboratory, it 
was very important to adequate the experimental conditions to improve results. In 
a 96-well plate, a feeder layer of 15 000 HeLa cells was plated and incubated 
overnight at 37ºC in 5% CO2, in order to be confluent in the following day 
(approximately 30 000 cells per well). To establish a ‘standard adhesion curve’, a 
preliminary test with increasing cell number was performed using HeLa cells, 
plated on the top of the feeder layer: 1x104, 2x104, 3x104, 5x104, 7,5x104 and 
10x104 cells. These were incubated for 1h at 37ºC in 5% CO2, following the 
protocol in Zepeda-Moreno et al (2011) [65]. Cells that did not adhere in this hour 
are allowed to fall into the medium by inverting the plate for another 1.5h. These 
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non-adherent cells were further collected with a micropipette into a new 96-well 
plate, and resazurin was added to quantify the non-adherent cells. We first tested 
a final end volume of 330 µL (medium plus resazurin), and incubated this for 4h at 
37ºC in 5% CO2. The experiment was performed in duplicate and culture medium 
was used as a negative control. After the 4h, the resazurin conversion was 
spectrophotometrically quantified. This experiment was unsuccessful since all the 
results were equal to the controls; this could mean that all cells adhered to the 
feeder layer (more unlikely, or that some technical problems were occurring.  
To dismiss that all HeLa cells were actually adhering, we apply the same 
experimental design, but using the less adherent CHO cell line as the top layer. A 
feeder layer of HeLa cells was again plated, and CHO cells were added in the 
following day at increasing cell number (Table 3, line A). CHO cells were also 
plated directly on the plastic bottom of the 96-well for comparison of the adherence 
efficiency (Table 3, line B). A row with only culture medium was used as a 
negative control (Table 3, row 8). After the 1h incubation (adhesion period) and the 
1.5h incubation (non-adhesion period), resazurin was added to the 300 µL of the 
supernatant, and incubated 4h at 37ºC in 5% CO2.  
A photograph of the 96-well plate following the 4h incubation period is 
shown in Figure 17A. Similarly, there were no differences between the test 
conditions and controls. To further evaluate whether these results reflected a short 
incubation period with resazurin, cells were left to incubate with resazurin 
overnight at 37ºC in 5% CO2. 
 
Table 3. Scheme of a 96-well plate used in the optimization of the cell-cell adhesion 
assay, with the number of increasing test cells plated onto the feeder layer, and respective 
negative controls. Line A: CHO cells plated onto the HeLa feeder layer. Line B: CHO cells 
plated directly on the plastic bottom of the plate. 
 
 
1 2 3 4 5 6 7 8 
A 1x10
4 
1,5x10
4 
2x10
4 
3x10
4 
4x10
4 
5,5x10
4 
7,5x10
4 Culture 
Medium 
B 1x10
4 
1,5x10
4 
2x10
4 
3x10
4 
4x10
4 
5,5x10
4 
7,5x10
4 Culture 
Medium 
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Figure 17. Colorimetric reaction following resazurin incubation. A. Resazurin was 
metabolized at very low extent after 4h of incubation and all samples were blue/purple. B. 
After resazurin overnight incubation, cells metabolized resazurin at a higher extent, and 
the medium colour changed to variations of pink. 
 
 
After increasing the incubation of cells with resazurin, some cells 
metabolized resazurin, resulting in a change of colour. A photograph of the 96-well 
plate following a overnight incubation period is shown in Figure 17B. These results 
were quantified spectrophotometrically, and are graphically presented in Figure 
18.  
Low concentrations of non-adherent cells, with slight fluctuations, can be 
observed for the lowest numbers of plated CHO cells until 30 000 cells, but at 40 
000 cells and after there was a linear increase in non-adherent cell concentration 
(Figure 18A). These results are expected: at lower plated cells number these are 
still able to adhere to the feeder layer, since the maximum theoretical number of 
cells per a 96-well plate is of approximately 30 000 (the expected 100% cell 
confluence). At higher numbers of plated cells it is understandable that there is a 
decrease in cellular adhesion due to space constriction. After reaching maximum 
cell confluence, the top cells layer begins to detach from feeder cells, as reflected 
by the higher cell concentration after 30 000 plated cells (Figure 18A). These 
results also indicate that this latest experimental design was functional for 
measuring non-adhesion cells. Of note, a shorter adhesion period of only 30 min 
was also tested (data not shown) but there were no differences between controls 
and CHO cells first incubated for 30 minutes, which implies that this is a short 
incubation period for this experiment. 
A 
B 
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Figure 18. Quantification of non-adherent CHO cells after 1h of adhesion period. A. CHO 
cells plated on a HeLa feeder layer. B. CHO cells plated on the plastic bottom. For the 
increasing number of plated CHO cells, the rate of resazurin conversion is shown, 
reflecting the non-adherent cells concentration. O.D.f, Final Optic Density.n=2 
 
 
Figure 18B shows that for the lower-to-medium plated cell number, CHO 
cells generally adhere better to the plastic than to HeLa cells (10 000 to 55 000 
cells). In fact, the number of non-adherent cells was irregular and only at the 
highest CHO plated number (75 000 cells), the concentration of non-adherent cells 
was higher in cells incubated on plastic than on HeLa cells (Figure 18B vs 18A). 
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5.2.2. Characterization of CHO and HeLa Cells Adhesion 
CHO-CHO and CHO-plastic Adhesion 
The optimized experimental design was then applied to a second set of cell-
cell adhesion assays, performed in triplicate, to analyse the adhesion behaviour of 
CHO and HeLa cells and establish standard curves of non-adherent CHO cells for 
the following antibody interference assays (section 5.4). 
 
 
 
 
Figure 19. Quantification of non-adherent CHO cells incubated for a 1h adhesion period. 
A. CHO cells plated on a CHO feeder layer. B. CHO cells plated directly on the plastic 
bottom. O.D.f, Final Optic Density. n= 3. 
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When CHO cells were plated on a CHO feeder layer, again adhesion was 
greater at lowest than at higher plated cells number (Figure 19A), similar to the 
previous preliminary results on a HeLa feeder layer (Figure 18A). The first two 
conditions (2x104 and 3x104 plated CHO cells) have very similar high adhesion 
results, and the further two (5x104 and 7.5x104 cells) present less adhesion (higher 
concentration of non-adherent cells). A more drastic loss of CHO-CHO cell 
adhesion occurs only at 10x104 and 15x104 plated CHO cells (Figure 19A). CHO 
on plastic adhesion results (Figure 19B) are also according to the preliminary ones 
on Figure 18B: the adhesion of CHO cells to the 96-well plate was very high, again 
higher than when cells are plated on to a cell feeder layer, since the number of 
non-adherent cells is quite low. After the 100% confluence, cells start to slightly 
detach (5-10x104 plated CHO cells) and only at the highest number tested 
(15x104) the concentration of non-adherent cells was very high, but again even 
higher than for the same number of cells plated on a CHO feeder layer (Figure 
19B vs 19A, 15x104 plated cells). 
 
CHO-HeLa Cells Adhesion 
 
 
 
Figure 20. Quantification of non-adherent CHO cells incubated for a 1h adhesion period. 
on a HeLa feeder layer. O.D.f, Final Optic Density. n= 3. 
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Similar to the previous CHO-HeLa adhesion assay results (Figure 18A): at 
the lowest numbers (2 and 3x104 plated cells) almost every cell adhere to the 
feeder layer. After the confluence threshold of 3x104 cells, CHO cells detach at a 
linear rate, with the number of non-adherent CHO cells linearly increasing with the 
number of CHO plated cells (Figure 20). 
 
HeLa-HeLa Cells and HeLa-Plastic Adhesion 
 
 
 
Figure 21. Quantification of non-adherent HeLa cells incubated for a 1h adhesion period. 
A. HeLa cells plated on a HeLa feeder layer. B. HeLa cells plated directly on the plastic 
bottom. O.D.f, Final Optic Density. n= 3. 
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The adhesive behaviour of the HeLa cells was also studied for comparison 
reasons (Figure 21). Curiously, almost every HeLa cell adhere to its HeLa feeder 
layer, even at the highest numbers of plated cells, with only slight variations 
between all tested plated numbers (Figure 21A). This implies that HeLa cells are 
able to grow overlapped and strengthens the highly adhesive properties of this cell 
line, indicating it as a valid choice for a feeder layer in cell-cell adhesion assays, 
but potentially not very useful as a top layer. Noticeable, the behaviour of HeLa 
cells adhesion to other HeLa cells or to plastic is very similar (Figure 21B vs 21A), 
thus reinforcing the adhesive properties of HeLa cells.  
 
5.2.3. Antibody Interference Assays 
The same CHO-HeLa cells experimental design was then used in antibody 
interference assays. A single antibody interference assay was first performed with 
each of the following antibodies: the 22C11 antibody against the extracellular APP 
N-terminus, the blocking anti-β1-integrin MAB1959 antibody, and the anti-ZP3 
domain antibody. Antibodies dilutions are presented in Table 1. 
 
Figure 22. Single antibody interference assay. The HeLa feeder cells or the CHO top cells 
were pre-incubated with the indicated antibodies before CHO cells plating. Two different 
CHO cell numbers were tested, pre- and after-confluence. In the control, no antibody was 
added. 
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As seen in Figure 22, interfering with APP and β1-integrin, either in HeLa or 
in CHO cells, increases the loss of CHO cells adhesion at 2x104 CHO plated cells. 
Interfering with ZP3, by its turn, does not seem to have an effect in cell adhesion. 
At 5x104 cells, blocking APP and β1-integrin in HeLa cells has a dramatic effect in 
the loss of CHO cells adhesion. Interfering with β1-integrin in CHO cells also 
increases the loss of adhesion, although at lower levels than when the antibody is 
used on HeLa cells. Of note, this reflects the stated much lower sensibility of this 
antibody to hamster cells (manufacturer’s data). Even at a higher CHO cell 
number, blocking ZP3 appears to have no effect in cell adhesion (Figure 22, ‘1:100 
ZP3’). Of note, a higher concentration of the ZP3 antibody (1:50) was tested (data 
not shown), but the results were very similar to the ones obtained with the 1:100 
dilution.   
 
 
 
Figure 23. ZP3 and APP co-interference assay. Before CHO cells plating, the HeLa 
feeder cells were pre-incubated with 22C11 to block APP, and the CHO top cells were 
pre-incubated with the anti-ZP3 antibody to block ZP3. Two different CHO cell numbers 
were tested, pre- and after-confluence. In the control, no antibody was added. 
 
When HeLa and CHO cells were simultaneously incubated with the anti-
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effect was similar to the one of APP alone, although a slight increase in the 
concentration of non-adherent cells (cumulative effect of both antibodies) could be 
observed, when compared with the single antibodies values (Figure 23, 2x104). At 
the highest CHO cell number tested, where the anti-APP antibody has a 
dramatically reducing effect in CHO adhesion, and the anti-ZP3 antibody alone 
has no effect, the presence of both antibodies appears to slightly decrease the 
number of non-adherent cells when compared to the 22C11 alone. Hence, 
blocking ZP3 in addition to APP seems to counteract the effect of blocking APP 
alone. 
 
 
 
Figure 24. ZP3 and β1-integrin co-interference assay. Before CHO cells plating, the HeLa 
feeder cells were pre-incubated with MAB1959 to block β1-integrin, and the CHO top cells 
were pre-incubated with the anti-ZP3 antibody to block ZP3. Two different CHO cell 
numbers were tested, pre- and after-confluence. In the control, no antibody was added. 
 
Blocking both β1-integrin in HeLa cells and ZP3 in CHO cells, at the 2x104 
CHO cells plating number, has a surprising cumulative interference effect in CHO-
HeLa cell adhesion (Figure 24). Indeed, there is an increase in the loss of 
adhesion when compared to each of the effects of the antibodies when alone. This 
cumulative increase has to be confirmed, as it is still statistically non-significant.  
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At the highest tested cell number (5x104), when interfering with β1-integrin 
alone still has a dramatic effect in the loss of adhesion, and interfering with ZP3 
has no observable effect in cell adhesion, blocking both proteins has again the an 
effect in adhesion, has the number of non-adherent cells increases comparing to 
controls, however this effect is still lower to that of β1-integrin alone. Similar to 
what happened in Figure 23 with APP and ZP3, it seems that adding ZP3 
decreases the effect of β1-integrin alone (Figure 24, ‘5x104‘). 
 
 
 
Figure 25. APP and β1-integrin co-interference assay. Before CHO cells plating, the HeLa 
feeder cells were pre-incubated with 22C11 to block APP, and the CHO top cells were 
pre-incubated with the MAB1959 to block β1-integrin. Two different CHO cell numbers 
were tested, pre- and after-confluence. In the control, no antibody was added. 
 
Regarding the effect of simultaneously block APP and β1-integrin, at the 
subconfluent cell number, when both APP and β1-integrin have single effects in 
cell adhesion, the blockage of both seems to have a slight cumulative effect 
(Figure 25, ‘2x104’). At the higher CHO cell number, blocking both proteins has 
again the surprising effect of counteracting the blocking effect of each of the 
antibodies alone, instead of having the expected cumulative effect observed at 
2x104 cells. In fact, there was a dramatic increase in cell adhesion when APP a 
β1-integrin are simultaneously blocked in each of the cell line (Figure 25, ‘5x104’). 
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5.3. Immunocytochemistry assays 
In the above antibody interference assays ZP3 appears to somehow 
influence cell-cell adhesion mediated by APP and β1-integrin. In order to better 
understand the ZP3 cellular effects, its potential co-localization with APP and β1-
integrin was investigated in CHO cells, HeLa cells, and in CHO-HeLa co-cultures. 
For analysing ZP3-APP co-localization, the 22C11 antibody was used to 
detect APP proteins inside cells and in the plasma membrane (Figure 26, red; ZP3 
in green). HeLa and CHO have a significant expression of both proteins, being 
these present throughout the cell in many vesicles, and with APP being specifically 
abundant in the Golgi apparatus. Of note, ZP3 has also a signal in the cells nuclei, 
particularly evident for CHO cells, what can be a physiological feature or a mere 
artefact. Regarding co-localization, there is some co-localization of ZP3 and APP 
in the Golgi, as expected, since both of them traffic through the secretory pathway. 
Generally, both ZP3 and APP are absent or present at low amounts at the plasma 
membrane of both cells, and no or few co-localization between them could be 
observed in cell-cell contact zones, even in the HeLa:CHO co-culture (Figure 26). 
In all the culture conditions tested, the presence of extracellular deposits of 
secreted ZP3 could be observed (Figure 27). This was especially evident in HeLa 
cells and in HeLa-CHO co-cultures, since HeLa have apparently higher levels of 
ZP3. The majority of these extracellular aggregates stained for APP, indicating the 
presence of this protein in secreted ZP3 oligomers. 
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Figure 26. Immunocytochemistry of ZP3 (green fluorescent) and APP (22C11, red 
fluorescent) in HeLa cells, CHO cells, and in HeLa-CHO co-cultures. Arrows indicate co-
localization. 
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Figure 27. Immunocytochemistry of ZP3 (green fluorescent) and APP (22C11, red 
fluorescent) in HeLa-CHO co-cultures. I and II indicate different ROIs (regions of interest) 
zooming in on the ZP3 extracellular aggregates. Arrows indicate the present of APP 
signal, co-localizing in these structures. 
 
For analysing ZP3-β1-integrin co-localization, the MAB1981 antibody was 
used to detect the N-terminus of β1-integrin proteins (Figure 28). In HeLa, as 
previously shown, ZP3 is found inside vesicles, distributed throughout the cell. β1-
integrin presents a similar distribution, but is more abundant in cells’ nuclei and at 
the PM than ZP3. There is a higher degree of co-localization between these 
proteins, when comparing to APP and ZP3. Co-localization is mainly observed in 
some vesicles, and also near or at the plasma membrane. Comparing to HeLa 
cells, CHO have a much lower β1-integrin signal, since this antibody does not 
recognize β1-integrin of hamster origin (data from the manufacturer). The images 
here presented are overexposed, resulting in a redder image (Figure 28, ‘CHO’). 
The distributions of ZP3 and β1-integrin are similar to the ones in HeLa cells but 
with lower co-localization. In the co-culture, since the β1-integrin antibody does not 
detected hamster epitopes, it was used as a marker to distinguish between CHO 
and HeLa cells. There was not a very high degree of co-localization between both 
proteins in points of contact between these cells. 
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Figure 28. Immunocytochemistry of ZP3 (green 
fluorescent) and β1-integrin (MAB1981, red fluorescent) 
in HeLa cells, CHO cells, and in HeLa-CHO co-cultures. 
Arrows indicate ZP3/ β1-integrin co-localization.  
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5.4. Immunoprecipitation Assays 
To analyse if APP and ZP3 physically interact, as indicated by the 
extracellular structures where they appear to co-localize (section 5.3), 
immunoprecipitation assays were performed. First, APP was immunoprecipitated 
with its CT695 antibody, in duplicate, but using two different magnetic beads linked 
to protein sepharose G (lane 2 and 3 of the IP). 
 
Figure 29. Immunoprecipitation of C-terminus of APP with western blot detection of co-
immunoprecipitated ZP3. A. WB of APP with the 22C11 antibody. B. WB of ZP3. C, 
control (no primary antibody, only beads). DB, dynabeads (Life Technologies), MB, 
Millipore beads Arrows indicate different forms of ZP3. HGly, Heavily glycosylated form of 
ZP3. Arrowheads indicate unspecific bands. 
 
Figure 29A shows that APP was efficiently immunoprecipitated by the 
CT695 antibody and the magnetic beads. In Figure 29B we can observe that the 
known 47 kDa ZP3 form could be co-immunoprecipitated with APP, but the dense 
signal from the immunoglobulins heavy chains around 50 kDa make it difficult to 
observe. A high glycosylated form of ZP3, slightly above 100 kDa (‘HGlyc ZP3’), 
appeared to be co-immunoprecipitated with APP. 
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To further clarify and confirm these results, APP and ZP3 were 
immunoprecipitated, either in the presence or absence of a crosslinker (DSP) to 
stabilize protein-protein interactions.  
 
 
 
 
 
Figure 30. Immunoprecipitation of C-terminus of APP (CT695 Ab) and ZP3 with and 
without crosslinker. A. Western blot was performed for APP (using 22C11) and ZP3. 
Arrows indicate different known forms of ZP3 of 47 and 92 kDa weights. “92 kDa” and 
arrowheads indicate heavily glycosylated forms of ZP3. B. Duplicate of experiment A, 
where highly glycosylated APP co-immunoprecipitated with ZP3 in the presence of the 
crosslinker. 
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Unfortunately, the beads here used (Millipore beads) also bound APP in 
the controls (Figure 30A, ‘C’ in IPs), either in the presence or in the absence of 
DSP, making it impossible to draw definitive conclusions. Nonetheless, the APP 
100-150 kDas forms are more abundant when the CT695 antibody is added 
(Figure 30A, ‘APP’ in IPs). We can also observe that highly molecular weight 
(HMW) APP forms are immunoprecipitated more abundantly with the antibodies 
against APP and ZP3, especially in the presence of the crosslinker (asterisk 
samples in IPs; highlighted in box). This has been observed in duplicate samples 
(Figure 30B).  
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6. Discussion and Conclusions 
Cell-cell adhesion is an important step in gamete interactions, and APP and 
ZP3 are proteins known to be involved in cell-cell adhesion. The distribution of the 
APP superfamily in the sperm cell, in particular in the sperm head and in the 
equatorial region [59], indicates a potential role for this protein (and APLPs) in 
sperm-oocyte adhesion. The ZP glycoprotein ZP3 is currently the main sperm 
receptor in oocyte-sperm interaction, and thus in this work we intended to 
understand if APP and ZP3 physically and functionally interact. Since a sperm-
oocyte model was not present in the laboratory (although available in the future 
through collaborations), we started the molecular evaluations by using 
approximate immortalized cell lines that express ZP3 and APP. The first choice 
comprehended CHO ovary cells and GC1 spermatogonia cells, but these later did 
not grow well. HeLa was a second option due to their high levels of APP, ZP3 and 
other proteins involved in cell-cell adhesion, such as β1-integrin.  
A first bioinformatics evaluation of ZP3 revealed some functional motifs that 
can be of great relevance for APP (section 5.1). For instance, the WW binding 
motif is also present in the APP binder protein Fe65, also believed to be involved 
with APP in cell-cell adhesion [63]. Further, both proteins can link high molecular 
weight carbohydrates such as glucosaminoglycans [60], and ZP3 can be 
phosphorylated by two kinases up-regulated by APP [82] and our unpublished 
work). This suggests that there may be a functional relationship between ZP3 and 
APP. 
The adhesion properties of these two glycosylated proteins, APP and ZP3, 
and their interaction in cell-cell adhesion, were further evaluated (section 5.2). An 
optimization of a reported cell-cell adhesion procedure was first performed for our 
cell lines. This method revealed to be very easy to execute, has a low cost, can be 
performed in a relatively short period of time, and only small amounts of antibodies 
are needed for the interference assays (section 5.2.1). 
When analysing the effects of APP and β1-integrin in cell adhesion, it is 
noticeable that the blockages of APP and β1-integrin alone (Figure 22) interfered 
dramatically with CHO-HeLa adhesion, confirming (as expected from the literature) 
that these two proteins play a crucial role in this process. Noteworthy, these 
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assays also confirm that the 22C11 can be used as a functional blocking antibody 
for APP. The addition of the β1-integrin antibody had a surprising biphasic effect 
on the 22C11-mediated cell detachment (Figure 25). At the lowest tested number 
(20 000 cells) the influence of both anti-APP and integrin antibodies appear to be 
slightly cumulative. This suggests that both APP and β1-integrin are involved in the 
same cell-cell adhesion pathway. However, at the highest number of plated cells 
(50 000), the cumulative effect is lost and their normal adhesion block, when 
alone, is completely annulled by the addition of the second blocking antibody 
(Figure 25).  
Blocking ZP3 alone (Figure 22) did not have an effect in disrupting cell 
adhesion either at the lowest or highest numbers of CHO plated cells, suggesting 
that it has no or very few adhesive properties by itself, at least for these cells. 
When both ZP3 and APP proteins were blocked in the interference assays, 
however, a very slight cumulative effect on disrupting cell adhesion may be 
observed at the lowest cell number. More interestingly even, when both ZP3 and 
APP were blocked, again we could observe a decrease in the adhesion disruption 
first provoked by the anti-APP antibody (Figure 23). Similarly, the simultaneous 
blockage of ZP3 and β1-integrin had as well this biphasic effect, just like the one 
seen with APP and ZP3 (Figure 24).  
The pre-confluence (20 000 cells) effects here observed are the typical 
ones observed when studying cell-cell adhesion, and relate to interactions 
between molecules in the plasma membranes of CHO and HeLa cells, and/or in 
their secreted extracellular matrices (ECM). The post-confluence (50 000 cells) 
effects, however, appear to also involve effects mediated by the feeder layer 
extracellular environment (see section 5.2.1, HeLa-CHO and CHO-CHO 
adhesion). For example, the alterations provoked by the contact of CHO cells (top 
layer) with feeder HeLa or CHO cells, turns CHO cells more adhesive at higher 
cell densities, when compared to the same cells only exposed to plastic (compare 
Figure 19B with Figure 19A and Figure 20). This has probably to due with the 
ECM secreted by these feeder layers during the 24h of previous incubation, which 
influence the adhesive proteome at the cell surface of the CHO top layer.  
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This does not explain why blocking two adhesive proteins simultaneously at 
higher cell densities impedes cell detachment. It is possible that, at an 
overconfluent cell number, there are more APP and β1-integrin molecules at the 
cell surface left to trans-interact with each other. From the immunocytochemistry 
assays we observed that APP, ZP3 and β1-integrin co-localize more in the same 
cell (in potentially cis-interactions) and less in cell-cell contacts. Blocking e.g. β1-
integrin in one layer and APP in the other layer may free their habitual cis-APP/ β1-
integrin interactors in the same cell, enabling them to CHO-HeLa trans-interact 
and thus support CHO adhesion. 
Overall, these results suggest that the main proteins involved in cell-cell 
adhesion are APP and β1-integrin, possibly through the same pathway. ZP3 alone 
seems to have only a slight role in adhesion, but appears to potentiate APP and 
β1-integrin-mediated cell-cell adhesion, interfering in the APP and β1-integrin 
pathway. 
As described previously, ZP3 and APP traffic through the secretary 
pathway. Immunocytochemistry assays showed that both proteins co-localized at 
low extent in the Golgi apparatus in CHO, HeLa and in a co-culture of both cell 
lines (Figure 26, arrows). A co-localization between these two proteins was further 
searched in the plasma membrane (PM), however this was very rare. A possible 
interaction between them at the PM cannot be completely ruled out, since this 
could be due to the low concentrations of APP and ZP3 in the cell membrane, 
highlighting that their presence at the PM is highly regulated. Surprisingly, 
extracellular aggregates of ZP3 were found in all tested cell lines, being 
particularly abundant in HeLa cells (Figures 26-28). In the great majority of these 
extracellular ZP3 aggregates we could observe some degree of co-localization 
with APP (Figure 27), and even with β1-integrin (Figure 28). This suggests that 
APP may interact with ZP3 dimers when they are both secreted into the ECM.  
The MAB1981 antibody we have used is almost non-functional in hamster 
samples. This is readily visible in the CHO cells cultures of Figure 28, which have 
a very low β1-integrin signal (red fluorescence). Therefore, in a co-culture of HeLa 
and CHO cells, ZP3 and β1-integrin have functioned as cell markers, facilitating 
the distinction between both cell lines (Figure 28, ‘co-culture’). We were not able to 
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observe considerable co-localization between these two proteins in different cells 
in contact. Contrary, in HeLa cells, ZP3 and β1-integrin co-localize with a higher 
degree than ZP3 and APP, especially at the plasma membrane (Figure 28). This is 
in accordance with their higher synergistic effect observed in the interference 
assays (Figure 24).  
From the immunoprecipitation assays it remained unclear whether APP and 
ZP3 physically interact (Figures 29 and 30). Although inconclusive, a possible 
interaction between ZP3 and APP potentially exists, in particular in between their 
highly glycosylated forms. This would be in line with the immunocytochemistry 
findings of their co-localization in aggregates of the ECM, but more experiments 
are needed to prove that these proteins physically interact and understand their 
relationship in cell-cell adhesion. This would be of particular interest in sperm-
oocyte interaction, where protein-carbohydrate interactions are accepted to be 
highly important [3], [12], [29]–[31], and glycosylation is crucial for triggering the 
acrosome reaction [29]–[31].  
Also importantly, in this work we cannot dismiss overlapping functions 
between APP and APLP2, with whom APP shares a high homology at its N-
terminus, and that is also recognized by the 22C11 antibody. 
 
Conclusions 
This work allowed the introduction of a novel cell-cell adhesion procedure in 
the laboratory that can be easily performed and is already optimized for each of 
the tested cell lines (HeLa and CHO).  
Regarding cell-cell adhesion, of all the studies proteins: APP, β1-integrin 
and ZP3, the first two appear to play a more crucial role in this process, possibly 
through a common pathway, while ZP3 appears to play a secondary role. ZP3 
slight effect in cell adhesion is potentially via interaction with APP and β1-integrin 
since it interferes with the effect of those proteins in cellular adhesion similarly as 
they do with each other. 
Intracellular ZP3 only co-localized at low amounts with APP, and in 
organelles involved in their secretory pathway. However, it showed a higher 
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degree of co-localization with β1-integrin in vesicles and at the plasma membrane. 
Unexpectedly, the presence of extracellular aggregates of ZP3, most of which 
contained small amounts of APP was observed. Some of those deposits appear to 
also have β1-integrin signal, potentially indicating that these aggregates form in 
ECM locations where β1-integrin exists. 
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Appendix 
Cell Culture Solutions and Immunocytochemistry 
 
 1x PBS 
 
For a final volume of 500 mL, dissolve one pack of BupH Modified 
Dulbecco’s Phosphate Buffered Saline Pack (Pierce) in deionised H2O. Final 
composition: 
 
- 8 mM Sodium Phosphate 
- 2 mM Potassium Phosphate 
- 40 mM Sodium Chloride 
- 10 mM Potassium Chloride 
 
Sterilize by filtering through a 0.2 m filter and store at 4ºC. 
 
 Complete DMEM (HeLa Cells) 
 
For a final volume of 1 L, when preparing DMEM medium adjust to pH 7.4 
and before sterilizing add: 
Fetal bovine Serum (FBS) (Gibco BRL, Invitrogen) 100 mL (10% v/v) 
 
Notes: For cell maintenance, prior to pH adjustment add 100 U/mL penicillin 
and 100 mg/mL streptomycin (100 mL Streptomycin/Penicilin/Amphotericin 
solution (Gibco BRL, Invitrogen)). 
 
 
 10% FBS Han’s F12 Nutrient Mixture + L-Glutamine (CHO) 
 
- F12 (Gibco, Invitrogen)                                                                   10,6g  
- NaHCO3 (Sigma)                                                                             1,5g 
- L-Glutamine (200mM stock solution)                                               2mL 
- Streptomycin/Penicillin/Amphotericin Solution (Gibco, Invitrogen)  10mL 
- 10% FBS (Gibco, Invitrogen)                                                           100mL 
 
Dissolve in distilled water (d) H2O and adjust the pH to 7.3. Finally, adjust 
volume to 1000 mL with dH2O. 
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 4% Paraformaldehyde 
For a final volume of 100 mL, add 4 g of paraformaldehyde to 25 mL 
deionised H2O. Dissolve by heating the mixture at 58ºC while stirring. Add 1-2 
drops of 1 M NaOH to clarify the solution and filter (0.2 m filter). Add 50 mL of 2X 
PBS and adjust the volume to 100 mL with deionised H2O. 
 
Immunoprecipitation Solutions 
 DSP 
 
Add 0,004g of DSP to 40 µL of DMSO. Dilute in 10mL of 1x PBS. 
 
 Lysis Buffer 
 
- 1M Tris HCl, pH 7.5                                   40 µL 
- NP-40 10%                                                200 µL 
- 1M NaCl                                                     600 µL 
- 0,25M EDTA                                               8 µL 
- 100mM PMSF                                            40 µL 
- Protease Inhibitors (1:1000)                       4 µL 
Adjust volume to 4 mL.  Keep it on ice. 
 
SDS-PAGE and Immunoblotting Solutions   
  
 LGB (Lower Gel Buffer) (4x) 
 
To 900 mL of deionised H2O add: 
 
- Tris 181.65 g 
- SDS 4 g 
Mix until the solutes have dissolved. Adjust the pH to 8.9 and adjust the 
volume to 1 L with deionised H2O. 
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 UGB (Upper Gel Buffer) (5x) 
To 900 mL of deionised H2O add: 
- Tris 75.69 g 
Mix until the solute has dissolved. Adjust the pH to 6.8 and adjust the 
volume to 1 L with deionised H2O. 
 
 30% Acrylamide/0.8% Bisacrylamide 
 
To 70 mL of deionised H2O add: 
 
- Acrylamide 29.2 g 
- Bisacrylamide 0.8 g 
 
Mix until the solutes have dissolved. Adjust the volume to 100 mL with 
deionised H2O. Filter through a 0.2 μm filter and store at 4°C. 
 
 10% APS (Ammonium Persulfate) 
 
In 10 mL of dH2O dissolve 1 g of APS. 
 
 10% SDS (Sodium Dodecilsulfate) 
 
In 10 mL of dH2O dissolve 1 g of SDS. 
 
 Loading Gel Buffer (4x) 
 
- 1 M Tris solution (pH 6.8) 2.5 ml (250 mM) 
- SDS 0.8 g (8%) 
- Glycerol 4 mL (40%)  
- β-Mercaptoethanol 2 mL (2%)  
- Bromophenol blue 1 mg (0.01 %) 
 
Adjust the volume to 10 mL with deionised H2O. Store in the darkness at 
room temperature. 
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 1 M Tris (pH 6.8) Solution 
 
To 150 mL of deonised H2O add: 
- Tris base 30.3 g 
Adjust the pH to 6.8 and adjust the final volume to 250 mL. 
 
 10x Running Buffer 
 
- Tris 30.3 g (250 mM) 
- Glycine 144.2 g (2.5 M) 
- SDS 10 g (1%) 
 
Dissolve in dH2O, adjust the pH to 8.3 and adjust the volume to 1 L. 
 
 Resolving (lower) Gel Solution (60 mL) 
 
                                                                    6.5%                 7.5% 
- H2O                                                           32 mL              29.25 mL 
- 30% Acryl/0.8% Bisacryl Solution             13 mL               15 mL 
- LGB (4x)                                                    15 mL               15 mL 
- 10% APS                                                   300 µL               30 µL 
- TEMED                                                      30 µL                 30 µL 
 
 Stacking (upper) Gel Solution (20 mL) 
 
                                                                    3.5%                  
- H2O                                                          13.2 mL               
- 30% Acryl/0.8% Bisacryl Solution             2.4 mL                
- UGB (5x)                                                   4 mL                
- 10% APS                                                   200 µL 
- 10% SDS                                                   200 µL  
- TEMED                                                      30 µL                
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 1x Transfer Buffer 
 
 - Tris 3.03 g (25 mM) 
- Glycine 14.41 g (192 mM) 
 
Mix until solutes dissolution. Adjust the pH to 8.3 with HCl and adjust the 
volume to 800 mL with dH2O. Just prior to use add 200 mL of methanol (20%). 
 
 10x TBS (Tris Buffered Saline) 
 
- Tris 12.11 g (10 mM) 
- NaCl 87.66 g (150 mM) 
 
Adjust the pH to 8.0 with HCl and adjust the volume to 1 L with dH2O. 
 
 10x TBST (TBS + Tween) 
 
- Tris 12.11 g (10 mM) 
- NaCl 87.66 g (150 mM) 
- Tween 20 5 mL (0.05 %) 
Adjust the pH to 8.0 with HCl and adjust the volume to 1 L with dH2O. 
 Membrane Stripping Solution 
 
- Tris-HCl (pH 6.7)                        3.76g (62.5 mM) 
- SDS                                            10g (2%) 
- β-marcaptoethanol                       3.5 mL (100mM) 
 
Dissolve Tris and SDS in dH2O and adjust with HCl to pH 6.7. Add the 
mercaptoethanol and adjust volume to 500 mL. 
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 ECL Home-made 
 
Solution A – ECL Luminol Solution (Stock Solution) 
- 20 mM Luminol (in DMSO)*                   1.25 mL (100 µM) 
- 100 mM 4-iodophenol (in DMSO)*         5 mL (2mM) 
- 0.1 M Tris (pH 9.35)                               125 mL (50 mM) 
 
Adjust volume to 250 mL with dH2O. 
* Protect form the light. 
 
Solution B – Hydrogen Peroxide 
